+关注
PCQ
暂无个人介绍
IP属地:未知
25
关注
3
粉丝
0
主题
0
勋章
主贴
热门
PCQ
2021-12-23
[Smile]
抱歉,原内容已删除
PCQ
2021-12-16
[Smile] [Smile]
Rebound Anticipated For Singapore Stock Market
PCQ
2021-12-11
[What]
Vaccine stocks dropped in morning trading
PCQ
2021-12-08
[Grin]
Apple shares rose more than 3% to a new high
PCQ
2021-12-07
okay
Grab shares slid more than 4% in premarket trading
PCQ
2021-12-05
[Sad]
Stocks gain on Friday to close out volatile week triggered by omicron fears
PCQ
2021-12-02
[Smile]
Apple shares rose nearly 2% to a new high
PCQ
2021-12-01
Okay
Oversold Singapore Bourse Called Lower Again
PCQ
2021-11-29
okay
抱歉,原内容已删除
PCQ
2021-11-23
interesting
Can Apple Close Above The All-Time Highs This Week? Option Analysis
PCQ
2021-11-23
Okay
抱歉,原内容已删除
PCQ
2021-11-22
Okay
抱歉,原内容已删除
PCQ
2021-11-19
[Smile]
抱歉,原内容已删除
PCQ
2021-11-18
Okay
抱歉,原内容已删除
PCQ
2021-11-17
okay
抱歉,原内容已删除
PCQ
2021-11-15
Okay!
抱歉,原内容已删除
PCQ
2021-11-13
interesting
抱歉,原内容已删除
PCQ
2021-11-12
Okay nice
抱歉,原内容已删除
PCQ
2021-11-10
okay
抱歉,原内容已删除
PCQ
2021-11-09
Okay
Buffett Signals Caution With Berkshire on Stock-Selling Streak
去老虎APP查看更多动态
{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"4087463284623270","uuid":"4087463284623270","gmtCreate":1624360404939,"gmtModify":1637631494654,"name":"PCQ","pinyin":"pcq","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":3,"headSize":25,"tweetSize":39,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖(非转发)","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.11.22","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.03.23","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":3,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":4,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":691559816,"gmtCreate":1640223175185,"gmtModify":1640223175185,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087463284623270","authorIdStr":"4087463284623270"},"themes":[],"htmlText":"[Smile] ","listText":"[Smile] ","text":"[Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691559816","repostId":"1183786099","repostType":2,"isVote":1,"tweetType":1,"viewCount":966,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690069678,"gmtCreate":1639614219904,"gmtModify":1639614219904,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087463284623270","authorIdStr":"4087463284623270"},"themes":[],"htmlText":"[Smile] [Smile] ","listText":"[Smile] [Smile] ","text":"[Smile] [Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/690069678","repostId":"1194155872","repostType":4,"repost":{"id":"1194155872","kind":"news","pubTimestamp":1639613035,"share":"https://www.laohu8.com/m/news/1194155872?lang=&edition=full","pubTime":"2021-12-16 08:03","market":"us","language":"en","title":"Rebound Anticipated For Singapore Stock Market","url":"https://stock-news.laohu8.com/highlight/detail?id=1194155872","media":"RTTNews","summary":"The Singapore stock market headed south again on Wednesday, one session after ending the two-day sli","content":"<p>The Singapore stock market headed south again on Wednesday, one session after ending the two-day slide in which it had fallen more than 20 points or 0.7 percent. The Straits Times Index now sits just beneath the 3,115-point plateau although it figures to bounce higher again on Thursday.</p>\n<p>The global forecast for the Asian markets is upbeat following results of the FOMC's monetary policy meeting. The European and U.S. markets were solidly higher and the Asian bourses figure to open in similar fashion.</p>\n<p>The STI finished modestly lower on Wednesday following losses from the properties and industrials, while the financials were mixed.</p>\n<p>For the day, the index slid 6.21 points or 0.20 percent to finish at 3,114.88 after trading between 3,106.63 and 3,120.55. Volume was 883.4 million shares worth 761.8 million Singapore dollars. There were 264 decliners and 180 gainers.</p>\n<p>Among the actives, Ascendas REIT lost 0.34 percent, while CapitaLand Integrated Commercial Trust retreated 0.50 percent, City Developments sank 0.42 percent, Comfort DelGro jumped 1.45 percent, Dairy Farm International plummeted 2.42 percent, DBS Group rose 0.19 percent, Genting Singapore surrendered 0.64 percent, Keppel Corp shed 0.39 percent, Mapletree Commercial Trust plunged 0.98 percent, Mapletree Logistics Trust declined 0.53 percent, Oversea-Chinese Banking Corporation fell 0.27 percent, SembCorp Industries skidded 0.51 percent, Singapore Airlines dipped 0.20 percent, Singapore Exchange slid 0.21 percent, SingTel dropped 0.41 percent, Thai Beverage tumbled 0.75 percent, United Overseas Bank collected 0.15 percent, Wilmar International tanked 0.96 percent and Yangzijiang Shipbuilding, Singapore Press Holdings, Singapore Technologies Engineering and SATS were unchanged.</p>\n<p>The lead from Wall Street is broadly positive as the major averages opened slightly lower on Wednesday but then surged in the afternoon to finish sharply higher.</p>\n<p>The Dow soared 383.25 points or 1.08 percent to finish at 35,927.43, while the NASDAQ spiked 327.94 points or 2.15 percent to end at 15,565.58 and the S&P 500 jumped 75.76 points or 1.63 percent to close at 4,709.85.</p>\n<p>The late-day rally on Wall Street came after the Fed announced its widely expected decision to accelerate the pace of reductions to its asset purchases program. Citing inflation developments and further improvement in the labor market, the Fed said it has decided to reduce the monthly pace of its net asset purchases by $30 billion per month, double the previously announced $15 billion per month.</p>\n<p>The Fed said it expects similar reductions in the pace of net asset purchases will likely be appropriate each month, pointing to an end to the program next March. Analysts partly attributed the subsequent rally to relief that the Fed was not more aggressive in accelerating the timetable for halting its asset purchases.</p>\n<p>Meanwhile, the Fed also announced its widely expected decision to keep the target range for the federal funds rate at zero to 0.25 percent. The central bank's latest projections forecast as many three rate hikes in 2022 compared to the lone rate hike forecast in September.</p>\n<p>Despite the prospect of sooner than expected rate hikes, analysts suggested traders were pleased with the increased level of certainty provided by the Fed's latest projections.</p>\n<p>Crude oil futures settled higher on Wednesday after the Energy Information Administration (EIA) said crude inventories in the U.S. dropped by 4.6 million barrels last week. West Texas Intermediate crude oil futures for January ended up by $0.14 or 0.2 percent at $70.87 a barrel.</p>","source":"lsy1626938412129","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Rebound Anticipated For Singapore Stock Market</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRebound Anticipated For Singapore Stock Market\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-16 08:03 GMT+8 <a href=https://www.rttnews.com/3249611/rebound-anticipated-for-singapore-stock-market.aspx><strong>RTTNews</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The Singapore stock market headed south again on Wednesday, one session after ending the two-day slide in which it had fallen more than 20 points or 0.7 percent. The Straits Times Index now sits just ...</p>\n\n<a href=\"https://www.rttnews.com/3249611/rebound-anticipated-for-singapore-stock-market.aspx\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"STI.SI":"富时新加坡海峡指数"},"source_url":"https://www.rttnews.com/3249611/rebound-anticipated-for-singapore-stock-market.aspx","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1194155872","content_text":"The Singapore stock market headed south again on Wednesday, one session after ending the two-day slide in which it had fallen more than 20 points or 0.7 percent. The Straits Times Index now sits just beneath the 3,115-point plateau although it figures to bounce higher again on Thursday.\nThe global forecast for the Asian markets is upbeat following results of the FOMC's monetary policy meeting. The European and U.S. markets were solidly higher and the Asian bourses figure to open in similar fashion.\nThe STI finished modestly lower on Wednesday following losses from the properties and industrials, while the financials were mixed.\nFor the day, the index slid 6.21 points or 0.20 percent to finish at 3,114.88 after trading between 3,106.63 and 3,120.55. Volume was 883.4 million shares worth 761.8 million Singapore dollars. There were 264 decliners and 180 gainers.\nAmong the actives, Ascendas REIT lost 0.34 percent, while CapitaLand Integrated Commercial Trust retreated 0.50 percent, City Developments sank 0.42 percent, Comfort DelGro jumped 1.45 percent, Dairy Farm International plummeted 2.42 percent, DBS Group rose 0.19 percent, Genting Singapore surrendered 0.64 percent, Keppel Corp shed 0.39 percent, Mapletree Commercial Trust plunged 0.98 percent, Mapletree Logistics Trust declined 0.53 percent, Oversea-Chinese Banking Corporation fell 0.27 percent, SembCorp Industries skidded 0.51 percent, Singapore Airlines dipped 0.20 percent, Singapore Exchange slid 0.21 percent, SingTel dropped 0.41 percent, Thai Beverage tumbled 0.75 percent, United Overseas Bank collected 0.15 percent, Wilmar International tanked 0.96 percent and Yangzijiang Shipbuilding, Singapore Press Holdings, Singapore Technologies Engineering and SATS were unchanged.\nThe lead from Wall Street is broadly positive as the major averages opened slightly lower on Wednesday but then surged in the afternoon to finish sharply higher.\nThe Dow soared 383.25 points or 1.08 percent to finish at 35,927.43, while the NASDAQ spiked 327.94 points or 2.15 percent to end at 15,565.58 and the S&P 500 jumped 75.76 points or 1.63 percent to close at 4,709.85.\nThe late-day rally on Wall Street came after the Fed announced its widely expected decision to accelerate the pace of reductions to its asset purchases program. Citing inflation developments and further improvement in the labor market, the Fed said it has decided to reduce the monthly pace of its net asset purchases by $30 billion per month, double the previously announced $15 billion per month.\nThe Fed said it expects similar reductions in the pace of net asset purchases will likely be appropriate each month, pointing to an end to the program next March. Analysts partly attributed the subsequent rally to relief that the Fed was not more aggressive in accelerating the timetable for halting its asset purchases.\nMeanwhile, the Fed also announced its widely expected decision to keep the target range for the federal funds rate at zero to 0.25 percent. The central bank's latest projections forecast as many three rate hikes in 2022 compared to the lone rate hike forecast in September.\nDespite the prospect of sooner than expected rate hikes, analysts suggested traders were pleased with the increased level of certainty provided by the Fed's latest projections.\nCrude oil futures settled higher on Wednesday after the Energy Information Administration (EIA) said crude inventories in the U.S. dropped by 4.6 million barrels last week. West Texas Intermediate crude oil futures for January ended up by $0.14 or 0.2 percent at $70.87 a barrel.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1616,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605267036,"gmtCreate":1639182635685,"gmtModify":1639182635685,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087463284623270","authorIdStr":"4087463284623270"},"themes":[],"htmlText":"[What] ","listText":"[What] ","text":"[What]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/605267036","repostId":"1148141788","repostType":4,"repost":{"id":"1148141788","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639147224,"share":"https://www.laohu8.com/m/news/1148141788?lang=&edition=full","pubTime":"2021-12-10 22:40","market":"us","language":"en","title":"Vaccine stocks dropped in morning trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1148141788","media":"Tiger Newspress","summary":"Vaccine stocks dropped in morning trading.Moderna,BioNTech and Novavax fell between 2% and 11%.","content":"<p>Vaccine stocks dropped in morning trading.Moderna,BioNTech and Novavax fell between 2% and 11%.</p>\n<p><img src=\"https://static.tigerbbs.com/d3f84cfc9f83b59cf14210d41d97111a\" tg-width=\"415\" tg-height=\"302\" width=\"100%\" height=\"auto\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vaccine stocks dropped in morning trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVaccine stocks dropped in morning trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-10 22:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Vaccine stocks dropped in morning trading.Moderna,BioNTech and Novavax fell between 2% and 11%.</p>\n<p><img src=\"https://static.tigerbbs.com/d3f84cfc9f83b59cf14210d41d97111a\" tg-width=\"415\" tg-height=\"302\" width=\"100%\" height=\"auto\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药","MRNA":"Moderna, Inc.","BNTX":"BioNTech SE"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1148141788","content_text":"Vaccine stocks dropped in morning trading.Moderna,BioNTech and Novavax fell between 2% and 11%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1306,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":606427974,"gmtCreate":1638922262420,"gmtModify":1638922262420,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087463284623270","authorIdStr":"4087463284623270"},"themes":[],"htmlText":"[Grin] ","listText":"[Grin] ","text":"[Grin]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/606427974","repostId":"1159685639","repostType":4,"repost":{"id":"1159685639","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638888367,"share":"https://www.laohu8.com/m/news/1159685639?lang=&edition=full","pubTime":"2021-12-07 22:46","market":"us","language":"en","title":"Apple shares rose more than 3% to a new high","url":"https://stock-news.laohu8.com/highlight/detail?id=1159685639","media":"Tiger Newspress","summary":"Apple shares rose more than 3% to a new high after the company got another street-high target on vir","content":"<p>Apple shares rose more than 3% to a new high after the company got another street-high target on virtual reality boost.</p>\n<p><img src=\"https://static.tigerbbs.com/eb9792aa89d24847aee38f67d56067eb\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p>\n<p>Apple Inc. got its second Street-high price target as Morgan Stanley sees it benefiting from new product categories in virtual reality and autonomous vehicles.</p>\n<p>Analyst Katy Huberty, who rates Apple overweight, raised her price target to $200 from $164, matching Wedbush as the highest among targets tracked by Bloomberg. </p>\n<p>While investors have struggled to value the iPhone maker’s new products given the company’s secrecy, Huberty expects augmented and virtual reality, as well as autonomous vehicles, to eventually be priced in, and says Apple should also benefit from a “flight to quality” in technology stocks.</p>\n<p>“Despite a consistent and material revenue contribution from new products and services over time, Apple shares don’t seem to bake in the impact from upcoming new product launches,” Huberty wrote in a note. “We believe this will change as Apple approaches the launch of an AR/VR product over the next year.”</p>\n<p><img src=\"https://static.tigerbbs.com/7d1d69bd985c3b74963515674f2da918\" tg-width=\"1200\" tg-height=\"675\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>Apple’s shares have surged 25% this year and ended Monday’s session at a fresh record. Investors consider the tech giant a safe bet in an increasingly volatile market, as the highest-valued names in the sector get hit by hawkish signals from the Federal Reserve.</p>\n<p>Huberty also increased her estimates for Apple’s December quarter, citing improving iPhone supply as manufacturing disruptions ease.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple shares rose more than 3% to a new high</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple shares rose more than 3% to a new high\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-07 22:46</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Apple shares rose more than 3% to a new high after the company got another street-high target on virtual reality boost.</p>\n<p><img src=\"https://static.tigerbbs.com/eb9792aa89d24847aee38f67d56067eb\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p>\n<p>Apple Inc. got its second Street-high price target as Morgan Stanley sees it benefiting from new product categories in virtual reality and autonomous vehicles.</p>\n<p>Analyst Katy Huberty, who rates Apple overweight, raised her price target to $200 from $164, matching Wedbush as the highest among targets tracked by Bloomberg. </p>\n<p>While investors have struggled to value the iPhone maker’s new products given the company’s secrecy, Huberty expects augmented and virtual reality, as well as autonomous vehicles, to eventually be priced in, and says Apple should also benefit from a “flight to quality” in technology stocks.</p>\n<p>“Despite a consistent and material revenue contribution from new products and services over time, Apple shares don’t seem to bake in the impact from upcoming new product launches,” Huberty wrote in a note. “We believe this will change as Apple approaches the launch of an AR/VR product over the next year.”</p>\n<p><img src=\"https://static.tigerbbs.com/7d1d69bd985c3b74963515674f2da918\" tg-width=\"1200\" tg-height=\"675\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>Apple’s shares have surged 25% this year and ended Monday’s session at a fresh record. Investors consider the tech giant a safe bet in an increasingly volatile market, as the highest-valued names in the sector get hit by hawkish signals from the Federal Reserve.</p>\n<p>Huberty also increased her estimates for Apple’s December quarter, citing improving iPhone supply as manufacturing disruptions ease.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1159685639","content_text":"Apple shares rose more than 3% to a new high after the company got another street-high target on virtual reality boost.\n\nApple Inc. got its second Street-high price target as Morgan Stanley sees it benefiting from new product categories in virtual reality and autonomous vehicles.\nAnalyst Katy Huberty, who rates Apple overweight, raised her price target to $200 from $164, matching Wedbush as the highest among targets tracked by Bloomberg. \nWhile investors have struggled to value the iPhone maker’s new products given the company’s secrecy, Huberty expects augmented and virtual reality, as well as autonomous vehicles, to eventually be priced in, and says Apple should also benefit from a “flight to quality” in technology stocks.\n“Despite a consistent and material revenue contribution from new products and services over time, Apple shares don’t seem to bake in the impact from upcoming new product launches,” Huberty wrote in a note. “We believe this will change as Apple approaches the launch of an AR/VR product over the next year.”\n\nApple’s shares have surged 25% this year and ended Monday’s session at a fresh record. Investors consider the tech giant a safe bet in an increasingly volatile market, as the highest-valued names in the sector get hit by hawkish signals from the Federal Reserve.\nHuberty also increased her estimates for Apple’s December quarter, citing improving iPhone supply as manufacturing disruptions ease.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1605,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":606310868,"gmtCreate":1638833792463,"gmtModify":1638833792463,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087463284623270","authorIdStr":"4087463284623270"},"themes":[],"htmlText":"okay","listText":"okay","text":"okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/606310868","repostId":"1191828969","repostType":2,"repost":{"id":"1191828969","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638792831,"share":"https://www.laohu8.com/m/news/1191828969?lang=&edition=full","pubTime":"2021-12-06 20:13","market":"us","language":"en","title":"Grab shares slid more than 4% in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1191828969","media":"Tiger Newspress","summary":"Grab shares slid more than 4% in premarket trading.The Singapore ride-hailing firm went on sale last week.","content":"<p>Grab shares slid more than 4% in premarket trading.The Singapore ride-hailing firm went on sale last week.</p>\n<p><img src=\"https://static.tigerbbs.com/8de30b544b65a645e7a91a37bfb8d8f8\" tg-width=\"851\" tg-height=\"618\" width=\"100%\" height=\"auto\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Grab shares slid more than 4% in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGrab shares slid more than 4% in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-06 20:13</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Grab shares slid more than 4% in premarket trading.The Singapore ride-hailing firm went on sale last week.</p>\n<p><img src=\"https://static.tigerbbs.com/8de30b544b65a645e7a91a37bfb8d8f8\" tg-width=\"851\" tg-height=\"618\" width=\"100%\" height=\"auto\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GRAB":"Grab Holdings"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1191828969","content_text":"Grab shares slid more than 4% in premarket trading.The Singapore ride-hailing firm went on sale last week.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1140,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":608147410,"gmtCreate":1638672022759,"gmtModify":1638672022759,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087463284623270","authorIdStr":"4087463284623270"},"themes":[],"htmlText":"[Sad] ","listText":"[Sad] ","text":"[Sad]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/608147410","repostId":"1115309845","repostType":4,"repost":{"id":"1115309845","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638541913,"share":"https://www.laohu8.com/m/news/1115309845?lang=&edition=full","pubTime":"2021-12-03 22:31","market":"us","language":"en","title":"Stocks gain on Friday to close out volatile week triggered by omicron fears","url":"https://stock-news.laohu8.com/highlight/detail?id=1115309845","media":"Tiger Newspress","summary":"Stocks rose in early trading Friday, looking past a disappointing November jobs report, as the marke","content":"<p>Stocks rose in early trading Friday, looking past a disappointing November jobs report, as the market nears the end of a roller-coaster week driven by Covid omicron variant developments.</p>\n<p>The Dow Jones Industrial Average rose about 100 points. The S&P 500 rose 0.43% and the technology-focused Nasdaq Composite rose 0.3%.</p>\n<p><img src=\"https://static.tigerbbs.com/f06b0aca63dcdc023083815943f6832a\" tg-width=\"1057\" tg-height=\"455\" referrerpolicy=\"no-referrer\"></p>\n<p>RLX Technology stock tumbled 6% as its Q3 <b>Net revenues</b> decreased by 34%.</p>\n<p>Marvell Technology shares soared 20% after delivering a better-than-expected earnings report and outlook.</p>\n<p>DocuSign shares tumbled 35% on Weak Sales Forecast.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stocks gain on Friday to close out volatile week triggered by omicron fears</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStocks gain on Friday to close out volatile week triggered by omicron fears\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-03 22:31</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Stocks rose in early trading Friday, looking past a disappointing November jobs report, as the market nears the end of a roller-coaster week driven by Covid omicron variant developments.</p>\n<p>The Dow Jones Industrial Average rose about 100 points. The S&P 500 rose 0.43% and the technology-focused Nasdaq Composite rose 0.3%.</p>\n<p><img src=\"https://static.tigerbbs.com/f06b0aca63dcdc023083815943f6832a\" tg-width=\"1057\" tg-height=\"455\" referrerpolicy=\"no-referrer\"></p>\n<p>RLX Technology stock tumbled 6% as its Q3 <b>Net revenues</b> decreased by 34%.</p>\n<p>Marvell Technology shares soared 20% after delivering a better-than-expected earnings report and outlook.</p>\n<p>DocuSign shares tumbled 35% on Weak Sales Forecast.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".DJI":"道琼斯",".IXIC":"NASDAQ Composite"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1115309845","content_text":"Stocks rose in early trading Friday, looking past a disappointing November jobs report, as the market nears the end of a roller-coaster week driven by Covid omicron variant developments.\nThe Dow Jones Industrial Average rose about 100 points. The S&P 500 rose 0.43% and the technology-focused Nasdaq Composite rose 0.3%.\n\nRLX Technology stock tumbled 6% as its Q3 Net revenues decreased by 34%.\nMarvell Technology shares soared 20% after delivering a better-than-expected earnings report and outlook.\nDocuSign shares tumbled 35% on Weak Sales Forecast.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1355,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":603593459,"gmtCreate":1638422373223,"gmtModify":1638422373401,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087463284623270","authorIdStr":"4087463284623270"},"themes":[],"htmlText":"[Smile] ","listText":"[Smile] ","text":"[Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/603593459","repostId":"1143092770","repostType":4,"repost":{"id":"1143092770","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638370804,"share":"https://www.laohu8.com/m/news/1143092770?lang=&edition=full","pubTime":"2021-12-01 23:00","market":"us","language":"en","title":"Apple shares rose nearly 2% to a new high","url":"https://stock-news.laohu8.com/highlight/detail?id=1143092770","media":"Tiger Newspress","summary":"Apple shares rose nearly 2% to a new high in morning trading.\nNeedham analyst Laura Martin said inve","content":"<p>Apple shares rose nearly 2% to a new high in morning trading.</p>\n<p><b>Needham</b> analyst Laura Martin said investors turned to Apple due to its prodigious cash flow capable of weathering the storm, not going bankrupt, not having financial distress.</p>\n<p>Martin said there are indications that Apple’s current products, especially its iPhone Pro models, are selling well, potentially leading to a big December quarter for the company.</p>\n<p>Tablets, especially the high-end iPhones, all of which say they’re going to have high margins and high revenue for the fourth quarter of this year, Martin added.</p>\n<p><img src=\"https://static.tigerbbs.com/edc1b3fcbf75cefc8acb5fa15512530b\" tg-width=\"840\" tg-height=\"470\" width=\"100%\" height=\"auto\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple shares rose nearly 2% to a new high</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple shares rose nearly 2% to a new high\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-01 23:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Apple shares rose nearly 2% to a new high in morning trading.</p>\n<p><b>Needham</b> analyst Laura Martin said investors turned to Apple due to its prodigious cash flow capable of weathering the storm, not going bankrupt, not having financial distress.</p>\n<p>Martin said there are indications that Apple’s current products, especially its iPhone Pro models, are selling well, potentially leading to a big December quarter for the company.</p>\n<p>Tablets, especially the high-end iPhones, all of which say they’re going to have high margins and high revenue for the fourth quarter of this year, Martin added.</p>\n<p><img src=\"https://static.tigerbbs.com/edc1b3fcbf75cefc8acb5fa15512530b\" tg-width=\"840\" tg-height=\"470\" width=\"100%\" height=\"auto\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1143092770","content_text":"Apple shares rose nearly 2% to a new high in morning trading.\nNeedham analyst Laura Martin said investors turned to Apple due to its prodigious cash flow capable of weathering the storm, not going bankrupt, not having financial distress.\nMartin said there are indications that Apple’s current products, especially its iPhone Pro models, are selling well, potentially leading to a big December quarter for the company.\nTablets, especially the high-end iPhones, all of which say they’re going to have high margins and high revenue for the fourth quarter of this year, Martin added.","news_type":1},"isVote":1,"tweetType":1,"viewCount":794,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":609716514,"gmtCreate":1638325513244,"gmtModify":1638325513244,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087463284623270","authorIdStr":"4087463284623270"},"themes":[],"htmlText":"Okay","listText":"Okay","text":"Okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/609716514","repostId":"1129769141","repostType":4,"repost":{"id":"1129769141","kind":"news","pubTimestamp":1638317199,"share":"https://www.laohu8.com/m/news/1129769141?lang=&edition=full","pubTime":"2021-12-01 08:06","market":"us","language":"en","title":"Oversold Singapore Bourse Called Lower Again","url":"https://stock-news.laohu8.com/highlight/detail?id=1129769141","media":"RTTNews","summary":"The Singapore stock market has finished lower in six straight trading days, sinking almost 200 point","content":"<p>The Singapore stock market has finished lower in six straight trading days, sinking almost 200 points or 6.4 percent along the way. The Straits Times Index now sits just above the 3,040-point plateau and it's got another weak lead for Wednesday's trade.</p>\n<p>The global forecast for the Asian markets suggests consolidation on continued COVID-19 worries and concerns over the outlook for interest rates. The European and U.S. markets were down and the Asian markets figure to open in similar fashion.</p>\n<p>The STI finished sharply lower on Tuesday with damage across the board, especially from the financials and industrials.</p>\n<p>For the day, the index plunged 79.29 points or 2.54 percent to finish at the daily low of 3,041.29 after peaking at 3,129.54. Volume was 3.22 billion shares worth 3.89 billion Singapore dollars. There were 338 decliners and 172 gainers.</p>\n<p>Among the actives, Ascendas REIT slumped 2.34 percent, while CapitaLand Integrated Commercial Trust and Jardine Cycle both fell 1.40 percent, City Developments added 0.29 percent, Comfort DelGro plummeted 4.20 percent, Dairy Farm International and Thai Beverage both weakened 2.19 percent, DBS Group declined 2.99 percent, Genting Singapore skidded 2.53 percent, Keppel Corp sank 2.11 percent, Mapletree Commercial Trust stumbled 2.39 percent, Mapletree Logistics Trust lost 1.87 percent, Oversea-Chinese Banking Corporation surrendered 3.17 percent, SATS retreated 2.56 percent, SembCorp Industries plunged 4.08 percent, Singapore Airlines slid 0.81 percent, Singapore Exchange tumbled 3.25 percent, Singapore Press Holdings eased 0.43 percent, Singapore Technologies Engineering was down 0.78 percent, SingTel dropped 2.07 percent, United Overseas Bank tanked 4.00 percent, Wilmar International shed 1.91 percent and Yangzijiang Shipbuilding was unchanged.</p>\n<p>The lead from Wall Street is broadly negative as the major averages opened lower on Tuesday and remained largely under water throughout the trading day.</p>","source":"lsy1626938412129","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Oversold Singapore Bourse Called Lower Again</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOversold Singapore Bourse Called Lower Again\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-01 08:06 GMT+8 <a href=https://www.rttnews.com/3245823/oversold-singapore-bourse-called-lower-again.aspx?type=acom><strong>RTTNews</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The Singapore stock market has finished lower in six straight trading days, sinking almost 200 points or 6.4 percent along the way. The Straits Times Index now sits just above the 3,040-point plateau ...</p>\n\n<a href=\"https://www.rttnews.com/3245823/oversold-singapore-bourse-called-lower-again.aspx?type=acom\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"C6L.SI":"新加坡航空公司","D05.SI":"星展集团控股","O39.SI":"华侨银行","STI.SI":"富时新加坡海峡指数","BVA.SI":"顶级手套有限公司"},"source_url":"https://www.rttnews.com/3245823/oversold-singapore-bourse-called-lower-again.aspx?type=acom","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1129769141","content_text":"The Singapore stock market has finished lower in six straight trading days, sinking almost 200 points or 6.4 percent along the way. The Straits Times Index now sits just above the 3,040-point plateau and it's got another weak lead for Wednesday's trade.\nThe global forecast for the Asian markets suggests consolidation on continued COVID-19 worries and concerns over the outlook for interest rates. The European and U.S. markets were down and the Asian markets figure to open in similar fashion.\nThe STI finished sharply lower on Tuesday with damage across the board, especially from the financials and industrials.\nFor the day, the index plunged 79.29 points or 2.54 percent to finish at the daily low of 3,041.29 after peaking at 3,129.54. Volume was 3.22 billion shares worth 3.89 billion Singapore dollars. There were 338 decliners and 172 gainers.\nAmong the actives, Ascendas REIT slumped 2.34 percent, while CapitaLand Integrated Commercial Trust and Jardine Cycle both fell 1.40 percent, City Developments added 0.29 percent, Comfort DelGro plummeted 4.20 percent, Dairy Farm International and Thai Beverage both weakened 2.19 percent, DBS Group declined 2.99 percent, Genting Singapore skidded 2.53 percent, Keppel Corp sank 2.11 percent, Mapletree Commercial Trust stumbled 2.39 percent, Mapletree Logistics Trust lost 1.87 percent, Oversea-Chinese Banking Corporation surrendered 3.17 percent, SATS retreated 2.56 percent, SembCorp Industries plunged 4.08 percent, Singapore Airlines slid 0.81 percent, Singapore Exchange tumbled 3.25 percent, Singapore Press Holdings eased 0.43 percent, Singapore Technologies Engineering was down 0.78 percent, SingTel dropped 2.07 percent, United Overseas Bank tanked 4.00 percent, Wilmar International shed 1.91 percent and Yangzijiang Shipbuilding was unchanged.\nThe lead from Wall Street is broadly negative as the major averages opened lower on Tuesday and remained largely under water throughout the trading day.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1670,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":600657865,"gmtCreate":1638150179895,"gmtModify":1638150179895,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087463284623270","authorIdStr":"4087463284623270"},"themes":[],"htmlText":"okay","listText":"okay","text":"okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/600657865","repostId":"1114522326","repostType":4,"isVote":1,"tweetType":1,"viewCount":1255,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":875170549,"gmtCreate":1637628510437,"gmtModify":1637628510437,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087463284623270","authorIdStr":"4087463284623270"},"themes":[],"htmlText":"interesting ","listText":"interesting ","text":"interesting","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/875170549","repostId":"1144786882","repostType":4,"repost":{"id":"1144786882","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1637627337,"share":"https://www.laohu8.com/m/news/1144786882?lang=&edition=full","pubTime":"2021-11-23 08:28","market":"us","language":"en","title":"Can Apple Close Above The All-Time Highs This Week? Option Analysis","url":"https://stock-news.laohu8.com/highlight/detail?id=1144786882","media":"Benzinga","summary":"What Happened:Apple Inc is having a volatile day, initially up over 2.5% but having since lost all o","content":"<p><b>What Happened:Apple Inc</b> is having a volatile day, initially up over 2.5% but having since lost all of those gains over the last two hours of trading.</p>\n<p>Trading activity has been strong with over 104 million shares on the day versus the 10-day average of 78 million. The recent sell-off late in the session might be due to supply constraints out of Asia for the upcoming holiday shopping season.</p>\n<p>But what is fascinating is the heavy level of options activity in the stock today with <b>over 2.73 million contracts traded on the day</b> (see below).</p>\n<p><img src=\"https://static.tigerbbs.com/1a3445e396564690250472543787b2dd\" tg-width=\"1002\" tg-height=\"277\" width=\"100%\" height=\"auto\"></p>\n<p><b>Why It Matters:</b>Prior to Monday, Apple had approximately 4.1 million calls and 3.3 million puts for a total of 7.4 million options. Thus, today's 2.7+ million options represent <b>a massive 36% increase in options in one day.</b></p>\n<p>Any time a stock trades 36% of the total options in one day, it suggests option traders are highly active in the stock. And considering 73% of the options traded were calls, it suggests option traders have a strong bullish bias.</p>\n<p><b>What's Next:</b> About half of the option flows today were short-dated (expiring Friday) with the largest concentration of strikes between $160 and $170 (image below).</p>\n<p><img src=\"https://static.tigerbbs.com/fdaae290e3e5538e2f6697fe9cbc40e9\" tg-width=\"1105\" tg-height=\"319\" width=\"100%\" height=\"auto\"></p>\n<p>The short-dated calls suggest option traders are targeting a range between $160 and $170 for the week. However, with the strong sell-off into the close, the stock could probe below the $160 strike.</p>\n<p>If Apple loses the $160 level, there is solid open interest down to the $155 strike, but falls off materially below that, so any sharp moves below here could represent a bigger selloff in the stock.</p>\n<p>Meanwhile, if the stock can break the all-time highs just above $165, there is potentially room for a move up towards the $175 level.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Can Apple Close Above The All-Time Highs This Week? Option Analysis</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCan Apple Close Above The All-Time Highs This Week? Option Analysis\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-11-23 08:28</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p><b>What Happened:Apple Inc</b> is having a volatile day, initially up over 2.5% but having since lost all of those gains over the last two hours of trading.</p>\n<p>Trading activity has been strong with over 104 million shares on the day versus the 10-day average of 78 million. The recent sell-off late in the session might be due to supply constraints out of Asia for the upcoming holiday shopping season.</p>\n<p>But what is fascinating is the heavy level of options activity in the stock today with <b>over 2.73 million contracts traded on the day</b> (see below).</p>\n<p><img src=\"https://static.tigerbbs.com/1a3445e396564690250472543787b2dd\" tg-width=\"1002\" tg-height=\"277\" width=\"100%\" height=\"auto\"></p>\n<p><b>Why It Matters:</b>Prior to Monday, Apple had approximately 4.1 million calls and 3.3 million puts for a total of 7.4 million options. Thus, today's 2.7+ million options represent <b>a massive 36% increase in options in one day.</b></p>\n<p>Any time a stock trades 36% of the total options in one day, it suggests option traders are highly active in the stock. And considering 73% of the options traded were calls, it suggests option traders have a strong bullish bias.</p>\n<p><b>What's Next:</b> About half of the option flows today were short-dated (expiring Friday) with the largest concentration of strikes between $160 and $170 (image below).</p>\n<p><img src=\"https://static.tigerbbs.com/fdaae290e3e5538e2f6697fe9cbc40e9\" tg-width=\"1105\" tg-height=\"319\" width=\"100%\" height=\"auto\"></p>\n<p>The short-dated calls suggest option traders are targeting a range between $160 and $170 for the week. However, with the strong sell-off into the close, the stock could probe below the $160 strike.</p>\n<p>If Apple loses the $160 level, there is solid open interest down to the $155 strike, but falls off materially below that, so any sharp moves below here could represent a bigger selloff in the stock.</p>\n<p>Meanwhile, if the stock can break the all-time highs just above $165, there is potentially room for a move up towards the $175 level.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1144786882","content_text":"What Happened:Apple Inc is having a volatile day, initially up over 2.5% but having since lost all of those gains over the last two hours of trading.\nTrading activity has been strong with over 104 million shares on the day versus the 10-day average of 78 million. The recent sell-off late in the session might be due to supply constraints out of Asia for the upcoming holiday shopping season.\nBut what is fascinating is the heavy level of options activity in the stock today with over 2.73 million contracts traded on the day (see below).\n\nWhy It Matters:Prior to Monday, Apple had approximately 4.1 million calls and 3.3 million puts for a total of 7.4 million options. Thus, today's 2.7+ million options represent a massive 36% increase in options in one day.\nAny time a stock trades 36% of the total options in one day, it suggests option traders are highly active in the stock. And considering 73% of the options traded were calls, it suggests option traders have a strong bullish bias.\nWhat's Next: About half of the option flows today were short-dated (expiring Friday) with the largest concentration of strikes between $160 and $170 (image below).\n\nThe short-dated calls suggest option traders are targeting a range between $160 and $170 for the week. However, with the strong sell-off into the close, the stock could probe below the $160 strike.\nIf Apple loses the $160 level, there is solid open interest down to the $155 strike, but falls off materially below that, so any sharp moves below here could represent a bigger selloff in the stock.\nMeanwhile, if the stock can break the all-time highs just above $165, there is potentially room for a move up towards the $175 level.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1374,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":875170061,"gmtCreate":1637628442357,"gmtModify":1637628442357,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087463284623270","authorIdStr":"4087463284623270"},"themes":[],"htmlText":"Okay","listText":"Okay","text":"Okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/875170061","repostId":"1122322848","repostType":4,"isVote":1,"tweetType":1,"viewCount":875,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":872766499,"gmtCreate":1637576322119,"gmtModify":1637576322119,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087463284623270","authorIdStr":"4087463284623270"},"themes":[],"htmlText":"Okay","listText":"Okay","text":"Okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/872766499","repostId":"2185826772","repostType":4,"isVote":1,"tweetType":1,"viewCount":303,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":876175969,"gmtCreate":1637286640802,"gmtModify":1637286640802,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087463284623270","authorIdStr":"4087463284623270"},"themes":[],"htmlText":"[Smile] ","listText":"[Smile] ","text":"[Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/876175969","repostId":"1168345410","repostType":4,"isVote":1,"tweetType":1,"viewCount":646,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":878226325,"gmtCreate":1637199210060,"gmtModify":1637199210060,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087463284623270","authorIdStr":"4087463284623270"},"themes":[],"htmlText":"Okay ","listText":"Okay ","text":"Okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/878226325","repostId":"1180752156","repostType":4,"isVote":1,"tweetType":1,"viewCount":632,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":871759657,"gmtCreate":1637115093499,"gmtModify":1637115101793,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087463284623270","authorIdStr":"4087463284623270"},"themes":[],"htmlText":"okay","listText":"okay","text":"okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/871759657","repostId":"1185179037","repostType":4,"isVote":1,"tweetType":1,"viewCount":362,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":873664166,"gmtCreate":1636939001730,"gmtModify":1636939001730,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087463284623270","authorIdStr":"4087463284623270"},"themes":[],"htmlText":"Okay!","listText":"Okay!","text":"Okay!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/873664166","repostId":"1102708415","repostType":4,"isVote":1,"tweetType":1,"viewCount":403,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":879457626,"gmtCreate":1636767229986,"gmtModify":1636767229986,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087463284623270","authorIdStr":"4087463284623270"},"themes":[],"htmlText":"interesting ","listText":"interesting ","text":"interesting","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/879457626","repostId":"1163118124","repostType":4,"isVote":1,"tweetType":1,"viewCount":430,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":879230715,"gmtCreate":1636727014411,"gmtModify":1636727014411,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087463284623270","authorIdStr":"4087463284623270"},"themes":[],"htmlText":"Okay nice","listText":"Okay nice","text":"Okay nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/879230715","repostId":"1104158261","repostType":4,"isVote":1,"tweetType":1,"viewCount":471,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":847697615,"gmtCreate":1636511453772,"gmtModify":1636511453902,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087463284623270","authorIdStr":"4087463284623270"},"themes":[],"htmlText":"okay ","listText":"okay ","text":"okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/847697615","repostId":"1179672442","repostType":4,"isVote":1,"tweetType":1,"viewCount":318,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":844155652,"gmtCreate":1636413228442,"gmtModify":1636413228916,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087463284623270","authorIdStr":"4087463284623270"},"themes":[],"htmlText":"Okay","listText":"Okay","text":"Okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/844155652","repostId":"1190184675","repostType":4,"repost":{"id":"1190184675","kind":"news","pubTimestamp":1636384600,"share":"https://www.laohu8.com/m/news/1190184675?lang=&edition=full","pubTime":"2021-11-08 23:16","market":"us","language":"en","title":"Buffett Signals Caution With Berkshire on Stock-Selling Streak","url":"https://stock-news.laohu8.com/highlight/detail?id=1190184675","media":"Bloomberg","summary":"(Bloomberg) -- Warren Buffett is signaling wariness with the soaring stock market as the billionaire","content":"<p>(Bloomberg) -- Warren Buffett is signaling wariness with the soaring stock market as the billionaire investor extends a selling streak.</p>\n<p>Buffett’s Berkshire Hathaway Inc. was a net seller of equities for the fourth straight quarter, a trend not seen in data going back to 2008. The company ended up selling almost $2 billion more in stocks than it purchased during the period, adding to a cash pile that climbed to a record $149.2 billion.</p>\n<p>The selling streak indicates Buffett has struggled to find bargains with the stock market hitting all-time highs. A big, splashy acquisition also eluded the conglomerate, as the 91-year old and his investing deputies confronted a combination of sky-high price tags and fierce competition from the wave of special purpose acquisition companies.</p>\n<p>“The big issue here is that Berkshire was a net seller of stocks again this quarter,” Jim Shanahan, an analyst with Edward Jones, said in a telephone interview. “That’s the primary culprit” of the cash pile continuing to rise.</p>\n<p>Berkshire’s sales appear to have largely come from cutting holdings in banks, insurance and financial investments, according to its third-quarter regulatory filing released Saturday. Berkshire has been paring certain stocks in recent periods, spending the second quarter trimming its investment in General Motors Co. and pulling back on some of its pharmaceutical bets. The company is set to release its third-quarter stock tweaks later this month.</p>\n<p>While Buffett’s been a consistent net seller these past four quarters, those sales have been relatively small compared with the massive size of his stock portfolio. Over the past nine months, he’s sold almost $7 billion more of stocks than he’s bought, roughly 2.2% of the fair value of Berkshire’s stock portfolio at the end of September.</p>\n<p>Buffett warned investors in May that Berkshire might not have much luck striking deals as SPACs gripped the market -- though he also predicted the boom probably wouldn’t last. Compounding the challenge, his most recent big acquisition, the $37 billion deal for Precision Castparts five years ago, resulted in a writedown that Buffett laid squarely at his own door.</p>\n<p>Berkshire isn’t alone in extending a cash pile amid the pandemic. Amazon.com Inc., Google-parent Alphabet Inc. and American Airlines Group Inc. were among companies that amassed significant holdings during the health crisis in a step analysts have said would likely lead to some acquisitions.</p>\n<p>And the rising cash pile is better than the alternative in the eyes of investors including Cheviot Value Management’s Darren Pollock. Even though Buffett’s cash pile still increased to a record despite the $7.6 billion of buybacks in the third quarter, Pollock says it’s a good sign about the health of Berkshire.</p>\n<p>“We’re happy with it because the alternative is that cash isn’t growing as much and that means that Berkshire’s operating companies aren’t of as high quality as we thought,” said Pollock, whose Cheviot owns shares in Berkshire. “To see that the cash is rising, to see that he’s deploying so much in one avenue which happens to be buybacks -- it’s not acquisitions -- but it’s being spent in a productive way, it’s so much better than the alternative of seeing that cash stabilize or decline without other large acquisitions.”</p>\n<p>Here are some other key takeaways from Berkshire’s third-quarter earnings on Saturday:</p>\n<p>Berkshire Appetite</p>\n<p>Buffett has increasingly leaned on share buybacks as one way to deploy billions of dollars. He’s spent about $51 billion on stock buybacks since a policy tweak in 2018, outpacing the $31 billion used to purchase shares of Apple Inc., Berkshire’s largest stock bet.</p>\n<p>In the third quarter, Berkshire bought back $7.6 billion of stock, surpassing the $6 billion of shares repurchased in the previous period.</p>\n<p>BNSF’s Record</p>\n<p>Record profit at Berkshire’s railroad, BNSF, and strong earnings from its energy businesses helped raise operating profit by 18% at the conglomerate during the third quarter.</p>\n<p>That also aided in offsetting a painful quarter for Berkshire’s insurers. Those businesses reported an underwriting loss that widened to $784 million amid heightened catastrophe costs and worsening claims trends at auto insurer Geico.</p>","source":"lsy1612507957220","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Buffett Signals Caution With Berkshire on Stock-Selling Streak</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBuffett Signals Caution With Berkshire on Stock-Selling Streak\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-08 23:16 GMT+8 <a href=https://finance.yahoo.com/news/buffett-signals-caution-berkshire-stock-140819517.html><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Bloomberg) -- Warren Buffett is signaling wariness with the soaring stock market as the billionaire investor extends a selling streak.\nBuffett’s Berkshire Hathaway Inc. was a net seller of equities ...</p>\n\n<a href=\"https://finance.yahoo.com/news/buffett-signals-caution-berkshire-stock-140819517.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BRK.A":"伯克希尔","BRK.B":"伯克希尔B"},"source_url":"https://finance.yahoo.com/news/buffett-signals-caution-berkshire-stock-140819517.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1190184675","content_text":"(Bloomberg) -- Warren Buffett is signaling wariness with the soaring stock market as the billionaire investor extends a selling streak.\nBuffett’s Berkshire Hathaway Inc. was a net seller of equities for the fourth straight quarter, a trend not seen in data going back to 2008. The company ended up selling almost $2 billion more in stocks than it purchased during the period, adding to a cash pile that climbed to a record $149.2 billion.\nThe selling streak indicates Buffett has struggled to find bargains with the stock market hitting all-time highs. A big, splashy acquisition also eluded the conglomerate, as the 91-year old and his investing deputies confronted a combination of sky-high price tags and fierce competition from the wave of special purpose acquisition companies.\n“The big issue here is that Berkshire was a net seller of stocks again this quarter,” Jim Shanahan, an analyst with Edward Jones, said in a telephone interview. “That’s the primary culprit” of the cash pile continuing to rise.\nBerkshire’s sales appear to have largely come from cutting holdings in banks, insurance and financial investments, according to its third-quarter regulatory filing released Saturday. Berkshire has been paring certain stocks in recent periods, spending the second quarter trimming its investment in General Motors Co. and pulling back on some of its pharmaceutical bets. The company is set to release its third-quarter stock tweaks later this month.\nWhile Buffett’s been a consistent net seller these past four quarters, those sales have been relatively small compared with the massive size of his stock portfolio. Over the past nine months, he’s sold almost $7 billion more of stocks than he’s bought, roughly 2.2% of the fair value of Berkshire’s stock portfolio at the end of September.\nBuffett warned investors in May that Berkshire might not have much luck striking deals as SPACs gripped the market -- though he also predicted the boom probably wouldn’t last. Compounding the challenge, his most recent big acquisition, the $37 billion deal for Precision Castparts five years ago, resulted in a writedown that Buffett laid squarely at his own door.\nBerkshire isn’t alone in extending a cash pile amid the pandemic. Amazon.com Inc., Google-parent Alphabet Inc. and American Airlines Group Inc. were among companies that amassed significant holdings during the health crisis in a step analysts have said would likely lead to some acquisitions.\nAnd the rising cash pile is better than the alternative in the eyes of investors including Cheviot Value Management’s Darren Pollock. Even though Buffett’s cash pile still increased to a record despite the $7.6 billion of buybacks in the third quarter, Pollock says it’s a good sign about the health of Berkshire.\n“We’re happy with it because the alternative is that cash isn’t growing as much and that means that Berkshire’s operating companies aren’t of as high quality as we thought,” said Pollock, whose Cheviot owns shares in Berkshire. “To see that the cash is rising, to see that he’s deploying so much in one avenue which happens to be buybacks -- it’s not acquisitions -- but it’s being spent in a productive way, it’s so much better than the alternative of seeing that cash stabilize or decline without other large acquisitions.”\nHere are some other key takeaways from Berkshire’s third-quarter earnings on Saturday:\nBerkshire Appetite\nBuffett has increasingly leaned on share buybacks as one way to deploy billions of dollars. He’s spent about $51 billion on stock buybacks since a policy tweak in 2018, outpacing the $31 billion used to purchase shares of Apple Inc., Berkshire’s largest stock bet.\nIn the third quarter, Berkshire bought back $7.6 billion of stock, surpassing the $6 billion of shares repurchased in the previous period.\nBNSF’s Record\nRecord profit at Berkshire’s railroad, BNSF, and strong earnings from its energy businesses helped raise operating profit by 18% at the conglomerate during the third quarter.\nThat also aided in offsetting a painful quarter for Berkshire’s insurers. Those businesses reported an underwriting loss that widened to $784 million amid heightened catastrophe costs and worsening claims trends at auto insurer Geico.","news_type":1},"isVote":1,"tweetType":1,"viewCount":308,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":600657865,"gmtCreate":1638150179895,"gmtModify":1638150179895,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087463284623270","idStr":"4087463284623270"},"themes":[],"htmlText":"okay","listText":"okay","text":"okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/600657865","repostId":"1114522326","repostType":4,"isVote":1,"tweetType":1,"viewCount":1255,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":878226325,"gmtCreate":1637199210060,"gmtModify":1637199210060,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087463284623270","idStr":"4087463284623270"},"themes":[],"htmlText":"Okay ","listText":"Okay ","text":"Okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/878226325","repostId":"1180752156","repostType":4,"isVote":1,"tweetType":1,"viewCount":632,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":875170061,"gmtCreate":1637628442357,"gmtModify":1637628442357,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087463284623270","idStr":"4087463284623270"},"themes":[],"htmlText":"Okay","listText":"Okay","text":"Okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/875170061","repostId":"1122322848","repostType":4,"isVote":1,"tweetType":1,"viewCount":875,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":876175969,"gmtCreate":1637286640802,"gmtModify":1637286640802,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087463284623270","idStr":"4087463284623270"},"themes":[],"htmlText":"[Smile] ","listText":"[Smile] ","text":"[Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/876175969","repostId":"1168345410","repostType":4,"isVote":1,"tweetType":1,"viewCount":646,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":873664166,"gmtCreate":1636939001730,"gmtModify":1636939001730,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087463284623270","idStr":"4087463284623270"},"themes":[],"htmlText":"Okay!","listText":"Okay!","text":"Okay!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/873664166","repostId":"1102708415","repostType":4,"isVote":1,"tweetType":1,"viewCount":403,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":846062060,"gmtCreate":1636035736976,"gmtModify":1636035737046,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087463284623270","idStr":"4087463284623270"},"themes":[],"htmlText":"interesting","listText":"interesting","text":"interesting","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/846062060","repostId":"1168874793","repostType":4,"repost":{"id":"1168874793","kind":"news","pubTimestamp":1636035446,"share":"https://www.laohu8.com/m/news/1168874793?lang=&edition=full","pubTime":"2021-11-04 22:17","market":"us","language":"en","title":"Ocugen: WHO Approval For Covaxin Is Potentially A Red Herring For Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=1168874793","media":"Seeking Alpha","summary":"Summary\n\nOcugen missed the opportunity to grab an Emergency Use Authorization for Covaxin in the US ","content":"<p><b>Summary</b></p>\n<ul>\n <li>Ocugen missed the opportunity to grab an Emergency Use Authorization for Covaxin in the US earlier this year, but it could still gain an approval via a pivotal immuno-bridging study.</li>\n <li>Meanwhile, Bharat has received WHO approval for Emergency Use Listing, meaning the vaccine can be distributed around the world - but that doesn't directly benefit Ocugen.</li>\n <li>There are numerous possibilities in play, and Ocugen has no shortage of backers and shorts - the stock is up >4,000% in the past year, but has trodden water for several months.</li>\n <li>It's hard to determine what may be in store next for Ocugen shareholders, but if I were one, I'd be holding and hoping. I recap the full story below.</li>\n</ul>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/25648bf13e5cb82880f748129c72261c\" tg-width=\"1536\" tg-height=\"1024\" width=\"100%\" height=\"auto\"><span>Klaus Vedfelt/DigitalVision via Getty Images</span></p>\n<p><b>Investment Thesis</b></p>\n<p>Bharat Biotech received an approval from the World Health Organization (\"WHO\") today to join the Emergency Use List (\"EUL\") for vaccines against COVID-19.</p>\n<p>As most investors will know, Ocugen (OCGN) holds the rights to distribute Covaxin in the US on behalf of Bharat, in exchange for a 45% share of all profits. It also has a similar deal in place for Canada, standing to earn 55% of all profits.</p>\n<p>Ocugen investors and shorts will be nervously waiting to see how today's news affects the biotech's share price, which initially jumped to $16, but has fallen to $12 post-market.</p>\n<p>In this post I recap the full story, updated from my last post in June, and offer some ways to think about Ocugen's share price in the short and long term.</p>\n<p><b>Ocugen Stock Jumps From $0.5 To $16 In 3 Months On Bharat COVID Vaccine Deal - The Story So Far</b></p>\n<p>Ocugen is one of the more bizarre biotech stories of 2021. In mid-December 2020, its shares were trading <$0.5, as the company struggled to develop a preclinical portfolio of gene therapy drug candidates targeting eye disease, having abandoned development of its lead candidate OCU300 in Graft vs Host Disease (\"GvHD\").</p>\n<p>A delisting from the Nasdaq looked a likely outcome for the company, but then Ocugen's fortunes changed dramatically - the biotech became a partner of Bharat Biotech, developer of the whole-virion inactivated vaccine candidate Covaxin, agreeing to help the Indian Pharma commercialise Covaxin in the US and Canada. Overnight, Ocugen's share price jumped to a price of $3, and by early February, it was trading at $16.</p>\n<p>I covered the full story in a note on Ocugen back in June, when Ocugen's shares were trading in a slightly more down-to-earth range of $6 - $10. At that time, the key question was whether Covaxin would receive an Emergency Use Authorization (\"EUA\") from the FDA, allowing it to be marketed and sold in the US.</p>\n<p>Unfortunately for Ocugen investors, delays in Bharat's trials of Covaxin in India, where outbreaks of COVID had suddenly become widespread, meant that Ocugen could not get positive Phase 3 trial data in front of the FDA in time for a deadline imposed by the US government - after which it would not accept any further EUA requests for COVID-19 vaccines for the remainder of the pandemic for those companies that have not already begun discussions with the FDA.</p>\n<p><b>Ocugen And Bharat Stay The Course - Trials Reveal Strong Efficacy</b></p>\n<p>The bad news about an EUA in the US did not deter Ocugen, Bharat, or Ocugen's investors, however. Despite heavy short interest, as many market watchers concluded Ocugen's share price would be decimated without an EUA for Covaxin in the US, Ocugen management felt that there were other options on the table, including obtaining an EUA in Canada, which falls under its agreement with Bharat, allowing Ocugen to earn 45% of all revenues earned in the region.</p>\n<p>The results of Bharat's ~@5k patient Phase 3 trial in India also came out positive.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/862520ed53c876fb96840a3cb9a7a6f9\" tg-width=\"640\" tg-height=\"317\" width=\"100%\" height=\"auto\"><span>Summary of results of Bharat Biotech Phase 3 trial of Covaxin. Source: Ocugen Corporate Presentation.</span></p>\n<p>As we can see above, Bharat's Covaxin (finally) delivered an efficacy readout of 77.8%, 93.4% efficacy against severe disease - and 65.2% efficacy against the delta variant - the most devastating of all the COVID strains. Furthermore, the National Institute of Allergies and Infectious Diseases advised that a novel vaccine adjuvant developed in Kansas, US with NIAID support, Alhydroxiquim-II, enhanced the overall efficacy of Covaxin.</p>\n<p><b>Bharat Pursues WHO Emergency Use Listing Whilst Ocugen Looks To Canada</b></p>\n<p>These results, as strong as they are - and it should be noted the efficacy of Pfizer (PFE) and BioNTech's (BNTX) messenger-RNA Comirnaty vaccine against the Delta variant has dropped as low as 39% in studies in Israel - they arrived too late to help Ocugen secure an EUA in the US.</p>\n<p>Ocugen turned its attention to Canada,announcing a rolling submission to Health Canada on July 15 through its affiliate, Vaccigen, Ltd<b>,</b>allowing for it to submit new data as and when it came in, accelerating the overall review process.</p>\n<p>If approved, Ocugen will earn 55% of all profits earned from the vaccine, but as I discussed in my last note when providing some discounted cash flow analysis based on optimistic and pessimistic scenarios, it's doubtful if the Canadian government's purchases alone would provide a significant boot to Ocugen's current market cap valuation of $2.5bn, or its share price of $12.7.</p>\n<p>The US is the key for Ocugen, and management has by no means given up on this opportunity. In late October, Ocugen made an Investigational New Drug (\"IND\") submission to the FDA. Ocugen's plan is to initiate a Phase 3 \"immuno-bridging study,\" enrolling several hundred healthy adults in the U.S, who will receive 2 doses of Covaxin or placebo, 28 days apart. The endpoints are described by management (in an October 27th press release) as follows:</p>\n<blockquote>\n The primary endpoint will compare blood-based samples taken from U.S. participants who received COVAXIN™ with samples of the participants in the Phase 3 efficacy trial conducted in India. The secondary endpoint involves testing the vaccine's immunogenic profile. The study will also evaluate safety and tolerability in the U.S. population.\n</blockquote>\n<p>Ocugen hopes to have the study complete before the end of H122, if it is approved by the FDA, which has yet to make a decision. If the FDA does give the green light, then the US market - and Ocugen's 45% of all profits - is suddenly back on the table.</p>\n<p>Meanwhile, Bharat Biotech received notification today that the World Health Organization has approved its application for an Emergency Use Listing (\"EUL\"), meaning Covaxin will now likely be accepted by a host of foreign governments, and that Indians who have received the vaccine will have fewer problems traveling overseas.</p>\n<p>It's great news for Bharat, who join the likes of Pfizer / BioNTech, Johnson & Johnson (JNJ), SinoPharm, Moderna (MRNA) and AstraZeneca (AZN) on the list of EUL-approved vaccine developers - but it is not necessarily great news for Ocugen.</p>\n<p>Vaccines on the EUL list are permitted to be sent to government's around the world as part of the COVAX scheme, designed to create equitable vaccine distribution around the world, including poorer countries, but the US is a donor to this scheme, not a beneficiary, meaning that Ocugen effectively gets no benefit, and no revenues, as a result of the WHO approval for Covaxin.</p>\n<p><b>Ocugen Stock Is Already On A Downtrend - All Eyes Will Now Be On Health Canada And The FDA</b></p>\n<p>Ocugen stock bounced from a price of ~$9, to a peak of ~$16 in trading today, however the share price quickly began to decline, and finished at a price of $12.7. Post-market, shares were down another 10%.</p>\n<p>That reflects the fact that the WHO approval for Covaxin does little to improve Ocugen's own fortunes, and in all honesty, was something of a red herring.</p>\n<p>Ocugen investors, and Ocugen shorts, are desperate to know what the future holds for Covaxin in the US and Canada, but they will have to wait until Health Canada and the FDA rule respectively on an Emergency Use Authorization, and an approval to begin a drastically reduced pivotal trial in the US.</p>\n<p>Ironically, despite all of the news flow and the publication of Covaxin Phase 3 trial data, and the EUA granted to Covaxin by the Indian government, Ocugen's fortunes are in a similar place to where they were when I last covered the company - barring the US EUA opportunity.</p>\n<p>That opportunity - the one that may have sent Ocugen shares through the roof - has gone, but as I argued in my last post, I think it's possible that the US would not object to stockpiling some of the Covaxin shot, which has a differentiated mechanism of action, and a shelf life of up to years if stored at 2- 8 degrees centigrade.</p>\n<p>Covaxin may have benefits that other vaccines do not, the reasoning may go, such as its ability to induce a Th1 response, conferring cell-mediated immunity and offering durable protection, and enhanced protection against COVID variants, which is the primary concern at the present time.</p>\n<p>On the other hand, the US may now be able to obtain supply directly from Bharat via the WHO and be in a position to cut Ocugen - the middleman - out of any deal.</p>\n<p>The fact of the matter is that Ocugen's opportunity with Bharat and Covaxin has always appeared to be one that required expediency of execution, in order to capitalize on a US market opportunity that's uncertain, perhaps negligible, at worst, and a potential multi-billion opportunity at best.</p>\n<p>Nobody knows even if Ocugen will get an opportunity to market Covaxin in the US, but if it does, it will need to negotiate a tricky Phase 3 trial first, which could take us into the latter half of next year. Equally, no-one yet knows if Health Canada will approve the vaccine.</p>\n<p><b>Conclusion</b></p>\n<p>To summarise the current state of affairs, I would lean toward an approval in Canada - if Covaxin is good enough for the WHO, why would it not be good enough for Canada?</p>\n<p>But how much product will Canada buy? Probably enough to create a substantial price spike for Ocugen stock, although demand is unlikely to be high enough to sustain that spike long term.</p>\n<p>How much would the US buy if Covaxin was approved in the US? Again, I cannot see it being a high enough volume to catapult Ocugen's market cap above say $10bn, but if it buys any at all, Ocugen's market valuation is more or less guaranteed to surge, at least temporarily.</p>\n<p>In conclusion, I would argue that there is enough intrigue and opportunity in the Ocugen story to keep investors interested - on both the short and long sides. The WHO approval does not directly benefit Ocugen revenues wise, but it's another win for Covaxin, which is in turn a win for Ocugen.</p>\n<p>If I has been holding Ocugen stock since December last year, when it traded at >$0.5, frankly I would have sold by now, but if I had opened a position at ~$10, in expectation of doubling my money on a US approval, I would still be (nervously) holding.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Ocugen: WHO Approval For Covaxin Is Potentially A Red Herring For Investors</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOcugen: WHO Approval For Covaxin Is Potentially A Red Herring For Investors\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-04 22:17 GMT+8 <a href=https://seekingalpha.com/article/4465154-ocugen-approval-for-covaxin-red-herring-for-investors><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Summary\n\nOcugen missed the opportunity to grab an Emergency Use Authorization for Covaxin in the US earlier this year, but it could still gain an approval via a pivotal immuno-bridging study.\n...</p>\n\n<a href=\"https://seekingalpha.com/article/4465154-ocugen-approval-for-covaxin-red-herring-for-investors\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"OCGN":"Ocugen"},"source_url":"https://seekingalpha.com/article/4465154-ocugen-approval-for-covaxin-red-herring-for-investors","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1168874793","content_text":"Summary\n\nOcugen missed the opportunity to grab an Emergency Use Authorization for Covaxin in the US earlier this year, but it could still gain an approval via a pivotal immuno-bridging study.\nMeanwhile, Bharat has received WHO approval for Emergency Use Listing, meaning the vaccine can be distributed around the world - but that doesn't directly benefit Ocugen.\nThere are numerous possibilities in play, and Ocugen has no shortage of backers and shorts - the stock is up >4,000% in the past year, but has trodden water for several months.\nIt's hard to determine what may be in store next for Ocugen shareholders, but if I were one, I'd be holding and hoping. I recap the full story below.\n\nKlaus Vedfelt/DigitalVision via Getty Images\nInvestment Thesis\nBharat Biotech received an approval from the World Health Organization (\"WHO\") today to join the Emergency Use List (\"EUL\") for vaccines against COVID-19.\nAs most investors will know, Ocugen (OCGN) holds the rights to distribute Covaxin in the US on behalf of Bharat, in exchange for a 45% share of all profits. It also has a similar deal in place for Canada, standing to earn 55% of all profits.\nOcugen investors and shorts will be nervously waiting to see how today's news affects the biotech's share price, which initially jumped to $16, but has fallen to $12 post-market.\nIn this post I recap the full story, updated from my last post in June, and offer some ways to think about Ocugen's share price in the short and long term.\nOcugen Stock Jumps From $0.5 To $16 In 3 Months On Bharat COVID Vaccine Deal - The Story So Far\nOcugen is one of the more bizarre biotech stories of 2021. In mid-December 2020, its shares were trading <$0.5, as the company struggled to develop a preclinical portfolio of gene therapy drug candidates targeting eye disease, having abandoned development of its lead candidate OCU300 in Graft vs Host Disease (\"GvHD\").\nA delisting from the Nasdaq looked a likely outcome for the company, but then Ocugen's fortunes changed dramatically - the biotech became a partner of Bharat Biotech, developer of the whole-virion inactivated vaccine candidate Covaxin, agreeing to help the Indian Pharma commercialise Covaxin in the US and Canada. Overnight, Ocugen's share price jumped to a price of $3, and by early February, it was trading at $16.\nI covered the full story in a note on Ocugen back in June, when Ocugen's shares were trading in a slightly more down-to-earth range of $6 - $10. At that time, the key question was whether Covaxin would receive an Emergency Use Authorization (\"EUA\") from the FDA, allowing it to be marketed and sold in the US.\nUnfortunately for Ocugen investors, delays in Bharat's trials of Covaxin in India, where outbreaks of COVID had suddenly become widespread, meant that Ocugen could not get positive Phase 3 trial data in front of the FDA in time for a deadline imposed by the US government - after which it would not accept any further EUA requests for COVID-19 vaccines for the remainder of the pandemic for those companies that have not already begun discussions with the FDA.\nOcugen And Bharat Stay The Course - Trials Reveal Strong Efficacy\nThe bad news about an EUA in the US did not deter Ocugen, Bharat, or Ocugen's investors, however. Despite heavy short interest, as many market watchers concluded Ocugen's share price would be decimated without an EUA for Covaxin in the US, Ocugen management felt that there were other options on the table, including obtaining an EUA in Canada, which falls under its agreement with Bharat, allowing Ocugen to earn 45% of all revenues earned in the region.\nThe results of Bharat's ~@5k patient Phase 3 trial in India also came out positive.\nSummary of results of Bharat Biotech Phase 3 trial of Covaxin. Source: Ocugen Corporate Presentation.\nAs we can see above, Bharat's Covaxin (finally) delivered an efficacy readout of 77.8%, 93.4% efficacy against severe disease - and 65.2% efficacy against the delta variant - the most devastating of all the COVID strains. Furthermore, the National Institute of Allergies and Infectious Diseases advised that a novel vaccine adjuvant developed in Kansas, US with NIAID support, Alhydroxiquim-II, enhanced the overall efficacy of Covaxin.\nBharat Pursues WHO Emergency Use Listing Whilst Ocugen Looks To Canada\nThese results, as strong as they are - and it should be noted the efficacy of Pfizer (PFE) and BioNTech's (BNTX) messenger-RNA Comirnaty vaccine against the Delta variant has dropped as low as 39% in studies in Israel - they arrived too late to help Ocugen secure an EUA in the US.\nOcugen turned its attention to Canada,announcing a rolling submission to Health Canada on July 15 through its affiliate, Vaccigen, Ltd,allowing for it to submit new data as and when it came in, accelerating the overall review process.\nIf approved, Ocugen will earn 55% of all profits earned from the vaccine, but as I discussed in my last note when providing some discounted cash flow analysis based on optimistic and pessimistic scenarios, it's doubtful if the Canadian government's purchases alone would provide a significant boot to Ocugen's current market cap valuation of $2.5bn, or its share price of $12.7.\nThe US is the key for Ocugen, and management has by no means given up on this opportunity. In late October, Ocugen made an Investigational New Drug (\"IND\") submission to the FDA. Ocugen's plan is to initiate a Phase 3 \"immuno-bridging study,\" enrolling several hundred healthy adults in the U.S, who will receive 2 doses of Covaxin or placebo, 28 days apart. The endpoints are described by management (in an October 27th press release) as follows:\n\n The primary endpoint will compare blood-based samples taken from U.S. participants who received COVAXIN™ with samples of the participants in the Phase 3 efficacy trial conducted in India. The secondary endpoint involves testing the vaccine's immunogenic profile. The study will also evaluate safety and tolerability in the U.S. population.\n\nOcugen hopes to have the study complete before the end of H122, if it is approved by the FDA, which has yet to make a decision. If the FDA does give the green light, then the US market - and Ocugen's 45% of all profits - is suddenly back on the table.\nMeanwhile, Bharat Biotech received notification today that the World Health Organization has approved its application for an Emergency Use Listing (\"EUL\"), meaning Covaxin will now likely be accepted by a host of foreign governments, and that Indians who have received the vaccine will have fewer problems traveling overseas.\nIt's great news for Bharat, who join the likes of Pfizer / BioNTech, Johnson & Johnson (JNJ), SinoPharm, Moderna (MRNA) and AstraZeneca (AZN) on the list of EUL-approved vaccine developers - but it is not necessarily great news for Ocugen.\nVaccines on the EUL list are permitted to be sent to government's around the world as part of the COVAX scheme, designed to create equitable vaccine distribution around the world, including poorer countries, but the US is a donor to this scheme, not a beneficiary, meaning that Ocugen effectively gets no benefit, and no revenues, as a result of the WHO approval for Covaxin.\nOcugen Stock Is Already On A Downtrend - All Eyes Will Now Be On Health Canada And The FDA\nOcugen stock bounced from a price of ~$9, to a peak of ~$16 in trading today, however the share price quickly began to decline, and finished at a price of $12.7. Post-market, shares were down another 10%.\nThat reflects the fact that the WHO approval for Covaxin does little to improve Ocugen's own fortunes, and in all honesty, was something of a red herring.\nOcugen investors, and Ocugen shorts, are desperate to know what the future holds for Covaxin in the US and Canada, but they will have to wait until Health Canada and the FDA rule respectively on an Emergency Use Authorization, and an approval to begin a drastically reduced pivotal trial in the US.\nIronically, despite all of the news flow and the publication of Covaxin Phase 3 trial data, and the EUA granted to Covaxin by the Indian government, Ocugen's fortunes are in a similar place to where they were when I last covered the company - barring the US EUA opportunity.\nThat opportunity - the one that may have sent Ocugen shares through the roof - has gone, but as I argued in my last post, I think it's possible that the US would not object to stockpiling some of the Covaxin shot, which has a differentiated mechanism of action, and a shelf life of up to years if stored at 2- 8 degrees centigrade.\nCovaxin may have benefits that other vaccines do not, the reasoning may go, such as its ability to induce a Th1 response, conferring cell-mediated immunity and offering durable protection, and enhanced protection against COVID variants, which is the primary concern at the present time.\nOn the other hand, the US may now be able to obtain supply directly from Bharat via the WHO and be in a position to cut Ocugen - the middleman - out of any deal.\nThe fact of the matter is that Ocugen's opportunity with Bharat and Covaxin has always appeared to be one that required expediency of execution, in order to capitalize on a US market opportunity that's uncertain, perhaps negligible, at worst, and a potential multi-billion opportunity at best.\nNobody knows even if Ocugen will get an opportunity to market Covaxin in the US, but if it does, it will need to negotiate a tricky Phase 3 trial first, which could take us into the latter half of next year. Equally, no-one yet knows if Health Canada will approve the vaccine.\nConclusion\nTo summarise the current state of affairs, I would lean toward an approval in Canada - if Covaxin is good enough for the WHO, why would it not be good enough for Canada?\nBut how much product will Canada buy? Probably enough to create a substantial price spike for Ocugen stock, although demand is unlikely to be high enough to sustain that spike long term.\nHow much would the US buy if Covaxin was approved in the US? Again, I cannot see it being a high enough volume to catapult Ocugen's market cap above say $10bn, but if it buys any at all, Ocugen's market valuation is more or less guaranteed to surge, at least temporarily.\nIn conclusion, I would argue that there is enough intrigue and opportunity in the Ocugen story to keep investors interested - on both the short and long sides. The WHO approval does not directly benefit Ocugen revenues wise, but it's another win for Covaxin, which is in turn a win for Ocugen.\nIf I has been holding Ocugen stock since December last year, when it traded at >$0.5, frankly I would have sold by now, but if I had opened a position at ~$10, in expectation of doubling my money on a US approval, I would still be (nervously) holding.","news_type":1},"isVote":1,"tweetType":1,"viewCount":99,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690069678,"gmtCreate":1639614219904,"gmtModify":1639614219904,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087463284623270","idStr":"4087463284623270"},"themes":[],"htmlText":"[Smile] [Smile] ","listText":"[Smile] [Smile] ","text":"[Smile] [Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/690069678","repostId":"1194155872","repostType":4,"repost":{"id":"1194155872","kind":"news","pubTimestamp":1639613035,"share":"https://www.laohu8.com/m/news/1194155872?lang=&edition=full","pubTime":"2021-12-16 08:03","market":"us","language":"en","title":"Rebound Anticipated For Singapore Stock Market","url":"https://stock-news.laohu8.com/highlight/detail?id=1194155872","media":"RTTNews","summary":"The Singapore stock market headed south again on Wednesday, one session after ending the two-day sli","content":"<p>The Singapore stock market headed south again on Wednesday, one session after ending the two-day slide in which it had fallen more than 20 points or 0.7 percent. The Straits Times Index now sits just beneath the 3,115-point plateau although it figures to bounce higher again on Thursday.</p>\n<p>The global forecast for the Asian markets is upbeat following results of the FOMC's monetary policy meeting. The European and U.S. markets were solidly higher and the Asian bourses figure to open in similar fashion.</p>\n<p>The STI finished modestly lower on Wednesday following losses from the properties and industrials, while the financials were mixed.</p>\n<p>For the day, the index slid 6.21 points or 0.20 percent to finish at 3,114.88 after trading between 3,106.63 and 3,120.55. Volume was 883.4 million shares worth 761.8 million Singapore dollars. There were 264 decliners and 180 gainers.</p>\n<p>Among the actives, Ascendas REIT lost 0.34 percent, while CapitaLand Integrated Commercial Trust retreated 0.50 percent, City Developments sank 0.42 percent, Comfort DelGro jumped 1.45 percent, Dairy Farm International plummeted 2.42 percent, DBS Group rose 0.19 percent, Genting Singapore surrendered 0.64 percent, Keppel Corp shed 0.39 percent, Mapletree Commercial Trust plunged 0.98 percent, Mapletree Logistics Trust declined 0.53 percent, Oversea-Chinese Banking Corporation fell 0.27 percent, SembCorp Industries skidded 0.51 percent, Singapore Airlines dipped 0.20 percent, Singapore Exchange slid 0.21 percent, SingTel dropped 0.41 percent, Thai Beverage tumbled 0.75 percent, United Overseas Bank collected 0.15 percent, Wilmar International tanked 0.96 percent and Yangzijiang Shipbuilding, Singapore Press Holdings, Singapore Technologies Engineering and SATS were unchanged.</p>\n<p>The lead from Wall Street is broadly positive as the major averages opened slightly lower on Wednesday but then surged in the afternoon to finish sharply higher.</p>\n<p>The Dow soared 383.25 points or 1.08 percent to finish at 35,927.43, while the NASDAQ spiked 327.94 points or 2.15 percent to end at 15,565.58 and the S&P 500 jumped 75.76 points or 1.63 percent to close at 4,709.85.</p>\n<p>The late-day rally on Wall Street came after the Fed announced its widely expected decision to accelerate the pace of reductions to its asset purchases program. Citing inflation developments and further improvement in the labor market, the Fed said it has decided to reduce the monthly pace of its net asset purchases by $30 billion per month, double the previously announced $15 billion per month.</p>\n<p>The Fed said it expects similar reductions in the pace of net asset purchases will likely be appropriate each month, pointing to an end to the program next March. Analysts partly attributed the subsequent rally to relief that the Fed was not more aggressive in accelerating the timetable for halting its asset purchases.</p>\n<p>Meanwhile, the Fed also announced its widely expected decision to keep the target range for the federal funds rate at zero to 0.25 percent. The central bank's latest projections forecast as many three rate hikes in 2022 compared to the lone rate hike forecast in September.</p>\n<p>Despite the prospect of sooner than expected rate hikes, analysts suggested traders were pleased with the increased level of certainty provided by the Fed's latest projections.</p>\n<p>Crude oil futures settled higher on Wednesday after the Energy Information Administration (EIA) said crude inventories in the U.S. dropped by 4.6 million barrels last week. West Texas Intermediate crude oil futures for January ended up by $0.14 or 0.2 percent at $70.87 a barrel.</p>","source":"lsy1626938412129","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Rebound Anticipated For Singapore Stock Market</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRebound Anticipated For Singapore Stock Market\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-16 08:03 GMT+8 <a href=https://www.rttnews.com/3249611/rebound-anticipated-for-singapore-stock-market.aspx><strong>RTTNews</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The Singapore stock market headed south again on Wednesday, one session after ending the two-day slide in which it had fallen more than 20 points or 0.7 percent. The Straits Times Index now sits just ...</p>\n\n<a href=\"https://www.rttnews.com/3249611/rebound-anticipated-for-singapore-stock-market.aspx\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"STI.SI":"富时新加坡海峡指数"},"source_url":"https://www.rttnews.com/3249611/rebound-anticipated-for-singapore-stock-market.aspx","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1194155872","content_text":"The Singapore stock market headed south again on Wednesday, one session after ending the two-day slide in which it had fallen more than 20 points or 0.7 percent. The Straits Times Index now sits just beneath the 3,115-point plateau although it figures to bounce higher again on Thursday.\nThe global forecast for the Asian markets is upbeat following results of the FOMC's monetary policy meeting. The European and U.S. markets were solidly higher and the Asian bourses figure to open in similar fashion.\nThe STI finished modestly lower on Wednesday following losses from the properties and industrials, while the financials were mixed.\nFor the day, the index slid 6.21 points or 0.20 percent to finish at 3,114.88 after trading between 3,106.63 and 3,120.55. Volume was 883.4 million shares worth 761.8 million Singapore dollars. There were 264 decliners and 180 gainers.\nAmong the actives, Ascendas REIT lost 0.34 percent, while CapitaLand Integrated Commercial Trust retreated 0.50 percent, City Developments sank 0.42 percent, Comfort DelGro jumped 1.45 percent, Dairy Farm International plummeted 2.42 percent, DBS Group rose 0.19 percent, Genting Singapore surrendered 0.64 percent, Keppel Corp shed 0.39 percent, Mapletree Commercial Trust plunged 0.98 percent, Mapletree Logistics Trust declined 0.53 percent, Oversea-Chinese Banking Corporation fell 0.27 percent, SembCorp Industries skidded 0.51 percent, Singapore Airlines dipped 0.20 percent, Singapore Exchange slid 0.21 percent, SingTel dropped 0.41 percent, Thai Beverage tumbled 0.75 percent, United Overseas Bank collected 0.15 percent, Wilmar International tanked 0.96 percent and Yangzijiang Shipbuilding, Singapore Press Holdings, Singapore Technologies Engineering and SATS were unchanged.\nThe lead from Wall Street is broadly positive as the major averages opened slightly lower on Wednesday but then surged in the afternoon to finish sharply higher.\nThe Dow soared 383.25 points or 1.08 percent to finish at 35,927.43, while the NASDAQ spiked 327.94 points or 2.15 percent to end at 15,565.58 and the S&P 500 jumped 75.76 points or 1.63 percent to close at 4,709.85.\nThe late-day rally on Wall Street came after the Fed announced its widely expected decision to accelerate the pace of reductions to its asset purchases program. Citing inflation developments and further improvement in the labor market, the Fed said it has decided to reduce the monthly pace of its net asset purchases by $30 billion per month, double the previously announced $15 billion per month.\nThe Fed said it expects similar reductions in the pace of net asset purchases will likely be appropriate each month, pointing to an end to the program next March. Analysts partly attributed the subsequent rally to relief that the Fed was not more aggressive in accelerating the timetable for halting its asset purchases.\nMeanwhile, the Fed also announced its widely expected decision to keep the target range for the federal funds rate at zero to 0.25 percent. The central bank's latest projections forecast as many three rate hikes in 2022 compared to the lone rate hike forecast in September.\nDespite the prospect of sooner than expected rate hikes, analysts suggested traders were pleased with the increased level of certainty provided by the Fed's latest projections.\nCrude oil futures settled higher on Wednesday after the Energy Information Administration (EIA) said crude inventories in the U.S. dropped by 4.6 million barrels last week. West Texas Intermediate crude oil futures for January ended up by $0.14 or 0.2 percent at $70.87 a barrel.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1616,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":872766499,"gmtCreate":1637576322119,"gmtModify":1637576322119,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087463284623270","idStr":"4087463284623270"},"themes":[],"htmlText":"Okay","listText":"Okay","text":"Okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/872766499","repostId":"2185826772","repostType":4,"isVote":1,"tweetType":1,"viewCount":303,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":847697615,"gmtCreate":1636511453772,"gmtModify":1636511453902,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087463284623270","idStr":"4087463284623270"},"themes":[],"htmlText":"okay ","listText":"okay ","text":"okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/847697615","repostId":"1179672442","repostType":4,"isVote":1,"tweetType":1,"viewCount":318,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":871759657,"gmtCreate":1637115093499,"gmtModify":1637115101793,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087463284623270","idStr":"4087463284623270"},"themes":[],"htmlText":"okay","listText":"okay","text":"okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/871759657","repostId":"1185179037","repostType":4,"isVote":1,"tweetType":1,"viewCount":362,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":879457626,"gmtCreate":1636767229986,"gmtModify":1636767229986,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087463284623270","idStr":"4087463284623270"},"themes":[],"htmlText":"interesting ","listText":"interesting ","text":"interesting","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/879457626","repostId":"1163118124","repostType":4,"repost":{"id":"1163118124","kind":"news","pubTimestamp":1636726239,"share":"https://www.laohu8.com/m/news/1163118124?lang=&edition=full","pubTime":"2021-11-12 22:10","market":"us","language":"en","title":"Tesla: $1 Trillion Of Speculation","url":"https://stock-news.laohu8.com/highlight/detail?id=1163118124","media":"Forbes","summary":"Tesla’s market cap surpassed the trillion-dollar mark, driven by a post-earnings rally that got a boost from the announcement of a 100,000-vehicle order from Hertz , which might not even happen.Even if it does come to pass, the Hertz order is a drop in the bucket of growth expectations baked into Tesla’s valuation. Tesla needs 155 Hertz-sized orders to justify the revenue expectations in its stock price. Put another way, the $1.2 trillion valuation implies Tesla owns 60%+ of the entire global p","content":"<p>Tesla’s (TSLA) market cap surpassed the trillion-dollar mark, driven by a post-earnings rally that got a boost from the announcement of a 100,000-vehicle order from Hertz (HTZ), which might not even happen.</p>\n<p>Even if it does come to pass, the Hertz order is a drop in the bucket of growth expectations baked into Tesla’s valuation. Tesla needs 155 Hertz-sized orders to justify the revenue expectations in its stock price. Put another way, the $1.2 trillion valuation implies Tesla owns 60%+ of the entire global passenger EV market and becomes more profitable than Apple (AAPL) by 2030.</p>\n<p>This report provides objective perspective on how outrageously high the valuation of Tesla stock is and the clear impracticality of the company meeting the expectations baked into its valuation.</p>\n<p><b>Tesla’s Valuation vs. Competitors Makes No Sense</b></p>\n<p>Tesla’s market cap is now greater than the next 10 largest (ranked by market cap) auto manufacturers combined.</p>\n<p><b>Figure 1: Tesla’s Market Cap Vs. Competitors</b></p>\n<p><img src=\"https://static.tigerbbs.com/fb58977e39c2d0ce868e80de26d098d9\" tg-width=\"925\" tg-height=\"393\" referrerpolicy=\"no-referrer\"></p>\n<p>This valuation comes despite Tesla selling less than 1/50th of the vehicles than the combined total sold by the next 10 largest automakers over the trailing twelve months ended the first half of 2021. See Figure 2.</p>\n<p>I cannot conceive of a straight-faced argument for the disconnect between Tesla’s valuation and its vehicle sales compared to its competitors.</p>\n<p><b>Figure 2: Tesla’s Car Sales Vs. Competitors</b></p>\n<p><img src=\"https://static.tigerbbs.com/7fe8de12677dc13fe01f38fbafdcab27\" tg-width=\"946\" tg-height=\"397\" referrerpolicy=\"no-referrer\">* Stellantis sales estimated as Fiat Chrysler and PSA Group’s 2H20 sales and Stellantis’ 1H21 sales. Stellantis was formed as a merger between the two in January 2021.</p>\n<p><b>Is the Hertz Deal Really Worth $100 Billion+ in Market Cap?</b></p>\n<p>Even if Hertz eventually agrees to buy 100,000 Tesla Model 3s, I do not think it is worth the $100 billion in market cap, or $1 million per vehicle, that we saw investors give Tesla’s market cap after the Hertz deal made headlines. Even Elon Musk questioned the surge in share price, noting that the price movement was “strange” given that Tesla is “very much a production ramp problem, not a demand problem.”</p>\n<p>This $100 billion market cap jump makes even less sense in the context of Tesla’s sky-high valuation before the announcement. Clearly, the feasibility of Tesla meeting the sales expectations embedded in its market cap plays no role in its valuation. For those that do care about expectations investing, I did the math and Tesla needs to successfully deliver on 155 Hertz-sized deals to meet the sales implied by a $1.2 trillion market cap.</p>\n<p><b>Will the Hertz Deal Result in Any Profits – If It Goes Through?</b></p>\n<p>After Elon Musk tweeted on November 1, 2021 that “no contract has been signed yet”, the Hertz deal reminds me of another famous tweet: \"am considering taking Tesla private at $420. Funding secured.”</p>\n<p>Even if the deal does go through, the pricing terms are very unclear. Elon insists that no cars will be sold at a discount. Meanwhile, Hertz CEO Mark Fields has made it clear that he is playing the field and working on getting cars from all EV manufacturers on his lot.</p>\n<p>Either Tesla is selling cars at a (large or small) discount, the deal terms are wrong, or the deal does not get done. If the deal gets done, I do not expect it to be profitable. Rental car companies are accustomed to getting discounts for bulk orders, and I see no reason for Hertz to expect to pay list prices on a deal for so many cars.</p>\n<p>At the end of the day, I’m not sure pricing matters because I don't think the Hertz deal gets done. This affair is more about headlines and fueling speculation than doing any real business.</p>\n<p><b>Tesla’s Global Market Share Getting Smaller</b></p>\n<p>Tesla’s first-mover is already eroding, and its market share continues to decline. In the first half of 2021, Tesla sold 14.6% of the EVs sold worldwide compared to 18.8% over the same period in 2020.</p>\n<p>Rising volumes, and falling market share are to be expected in a nascent industry. The problem is that Tesla’s isn’t priced for declining market share. It is priced for massive market share gains, unheard of gains in nearly any industry across the globe, especially in an industry as large and competitive as passenger vehicles.</p>\n<p><b>Reverse DCF Math: Valuation Implies Tesla Will Own 60%+ of the Global Passenger EV Market</b></p>\n<p>At its current average selling price (ASP) of ~$51k, Tesla’s stock price of ~1,200/share implies the firm will sell 16 million vehicles in 2030 (versus ~800k TTM), or 60% of the projected base case global EV passenger vehicle market in 2030. For reference, Adam Jonas, a Morgan Stanley analyst with a price target of $1,600/share, projects Tesla will sell 8.1 million vehicles in 2030.</p>\n<p>I think it is unlikely that Tesla will sell such a high volume of vehicles at a $51k ASP, yet the implied vehicle sales based on lower ASPs look even more impractical.</p>\n<p>As detailed in the next section, this analysis assumes Tesla achieves profit margins twice as high as Toyota (TM) and quadruples its current auto manufacturing efficiency. In other words, I aim to provide inarguably best-case scenarios for assessing the expectations reflected in Tesla’s stock price.</p>\n<p>Per Figure 3, Tesla’s current valuation implies that, in 2030, it will sell the following number of vehicles based on these ASP benchmarks:</p>\n<ul>\n <li>16 million vehicles – current ASP of $51k</li>\n <li>21 million vehicles – ASP of $38k (average new car price in the U.S. in 2020)</li>\n <li>46 million vehicles – ASP of $17k (equal to General Motors over the TTM)</li>\n</ul>\n<p>If Tesla achieves those EV sales, the implied market share for the company would be the following (assuming global passenger EV sales reach 25.8 million in 2030, the base case projection from the IEA):</p>\n<ul>\n <li>60% for 16 million vehicles</li>\n <li>80% for 21 million vehicles</li>\n <li>179% for 46 million vehicles</li>\n</ul>\n<p>If I assume the IEA’s best case for global passenger EV sales in 2030, 46.8 million vehicles, the above vehicle sales represent:</p>\n<ul>\n <li>33% for 16 million vehicles</li>\n <li>44% for 21 million vehicles</li>\n <li>98% for 46 million vehicles</li>\n</ul>\n<p><b>Figure 3: Tesla’s Implied Vehicle Sales in 2030 to Justify Current Valuation</b></p>\n<p><img src=\"https://static.tigerbbs.com/9c6d6230910209d16f55e6e527130d43\" tg-width=\"960\" tg-height=\"376\" referrerpolicy=\"no-referrer\"><b>The Math Shows that Tesla Must be More Profitable Than Apple</b></p>\n<p>Here are the assumptions I use in my reverse discounted cash flow (DCF) model to calculate the implied production levels above.</p>\n<p>To justify its current price of ~$1,200/share, Tesla must:</p>\n<ul>\n <li>immediately achieve a 17.2% NOPAT margin (double Toyota’s margin, which is the highest of the large-scale automakers I cover), compared to Tesla’s TTM margin of 7.7%) and</li>\n <li>grow revenue by 38% compounded annually for the next decade.</li>\n</ul>\n<p>In this scenario, Tesla generates <b>$783 billion</b> in revenue in 2030, which is 102% of the combined revenues of Toyota, General Motors, Ford (F), Honda Motor Corp (HMC), and Stellantis (STLA) over the TTM.</p>\n<p>This scenario also implies Tesla generates $135 billion in net operating profit after-tax (NOPAT) in 2030, or 45% higher than Apple’s (AAPL) TTM NOPAT, which, at $93 billion, is the highest of all companies my firm covers.</p>\n<p><b>TSLA Has 60%+ Downside If Morgan Stanley Is Right About Sales</b></p>\n<p>If I assume Tesla reaches Morgan Stanley’s estimate of selling 8.1 million cars in 2030 (which implies a 31% share of the global passenger EV market in 2030), at an ASP of $38k, the stock is worth just $483/share. Details:</p>\n<ul>\n <li>NOPAT margin improves to 17.2% and</li>\n <li>revenue grows 27% compounded annually over the next decade, then</li>\n</ul>\n<p>the stock is worth just $483/share today – 60% downside to the current price. See the math behind this reverse DCF scenario. In this scenario, Tesla grows NOPAT to $60 billion, or nearly 17x its TTM NOPAT, and just 3% below Alphabet’s (GOOGL) TTM NOPAT.</p>\n<p><b>TSLA Has 88%+ Downside Even with 28% Market Share and Realistic Margins</b></p>\n<p>If I estimate more reasonable (but still very optimistic) margins and market share achievements for Tesla, the stock is worth just $148/share. Here’s the math:</p>\n<ul>\n <li>NOPAT margin improves to 8.5% (equal to General Motors’ TTM margin, compared to Tesla’s TTM margin of 7.7%) and</li>\n <li>revenue grows by consensus estimates from 2021-2023 and</li>\n <li>revenue grows 18% a year from 2024-2030, then</li>\n</ul>\n<p>the stock is worth just $148/share today – an 88% downside to the current price.</p>\n<p>In this scenario, Tesla sells 7.2 million cars (at an ASP of 38k) and owns 28% of the global passenger EV market in 2030. If Tesla fails to meet these expectations, then the stock is worth less than $148/share.</p>\n<p>Also, for this scenario, I assume a much more realistic NOPAT margin, 8.5%, for Tesla. Given the expansion required of the business, struggles to be profitable to date, and formidable competition, I think Tesla will be lucky to achieve and sustain a margin as high as 8.5% from 2021-2030.</p>\n<p>Figure 4 compares the firm’s historical NOPAT to the NOPAT implied by its current stock price, the 8.1 million vehicle sales scenario, and the 7.2 million vehicle sales scenario to illustrate just how high the expectations baked into Tesla’s stock price remain. For additional context, I show Toyota’s, General Motors’, and Apple’s TTM NOPAT.</p>\n<p><b>Figure 4: Tesla’s Historical and Implied NOPAT: DCF Valuation Scenarios</b></p>\n<p><img src=\"https://static.tigerbbs.com/25d334530f3477d58879490d628fa8ef\" tg-width=\"936\" tg-height=\"463\" referrerpolicy=\"no-referrer\"></p>\n<p>Each of the above scenarios assumes Tesla’s invested capital grows 14% compounded annually through 2030. For reference, Tesla’s invested capital grew 53% compounded annually from 2010-2020 and 29% compounded annually from 2015-2020. Invested capital at the end of 3Q21 grew 21% YoY. Tesla’s property, plant, and equipment has grown even faster, at 58% compounded annually, since 2010.</p>\n<p>A 14% CAGR represents 1/4th the CAGR of Tesla’s property, plant, and equipment since 2010 and assumes the company can build future plants and produce cars 4x more efficiently than it has so far.</p>\n<p>In other words, I aim to provide inarguably best-case scenarios for assessing the expectations for future market share and profits reflected in Tesla’s stock market valuation.</p>\n<p><b>Why Tesla’s $1 Trillion Valuation Is Ridiculous</b></p>\n<p>Now that I’ve shown how high the expectations baked into Tesla’s valuation are, I’ll present some of the many challenges Tesla faces to meet those expectations.</p>\n<p><b>Tesla Remains “Just” a Car Company, Despite Bulls’ Arguments Otherwise.</b>One of the most common arguments bulls make to justify Tesla’s valuation is that the company is more than just a car company. Instead, the argument goes: Tesla is a software, tech, insurance, energy, transportation, “insert any other blank” company. However, the financials bear out a different picture and show the other businesses are more hype than substance. At this point, Tesla is a only car company and generates the entirety of its profits from vehicles.</p>\n<p>Per Figure 5, Tesla generated 88% of revenue from Automotive Sales in 3Q21, which is up from 87% in 3Q20, and above the quarterly average of 86% since 3Q19. For reference, automotive sales made up 87% and 93% of General Motors’ and Ford’s 3Q21 revenue respectively.</p>\n<p><b>Figure 5: Tesla’s Revenue Breakdown: 3Q19 – 3Q21</b></p>\n<p><img src=\"https://static.tigerbbs.com/4b77f52dfd7a9cb05f19a91ac8811919\" tg-width=\"960\" tg-height=\"419\" referrerpolicy=\"no-referrer\">Tesla’s two other segments, Energy generation and storage and Services and other, which make up 12% of revenue in 3Q21, are unprofitable. Over the TTM, Tesla generated $10.8 billion in gross profit. $11.2 billion came from its Automotive segment while Energy generation and storage and Services and other racked up gross losses of $113 million and $263 million. Despite many claims and promises to the contrary over the years, Tesla doesn’t generate gross profit doing anything but selling cars.</p>\n<p><b>Insurance Business Is Not Material.</b> Tesla bulls will also point to Tesla’s insurance business as another way to drive profit growth. I’ve previously covered how Tesla insurance does not have the competitive advantages that bulls ascribe to it and has a long way to go before it can get meaningfully off the ground.</p>\n<p>Even if Tesla’s insurance business gets off the ground, I would not expect it to make much money. For example, from 2004-2006, General Motors generated about $70 per car sold in GAAP net income from its insurance business. If I assume Tesla can generate the same level of business, Tesla insurance would result in just $57 million in GAAP net income based on TTM vehicles sold.</p>\n<p>Bulls will counter that Tesla will be so much better at insurance than GM and that GM is not a good comp. There is no way to know for sure. Nevertheless, I concede that anything is possible, but the likelihood of Tesla’s insurance business being material profit producer is extremely low.</p>\n<p>Regardless of how successful Tesla insurance is, the potential profits from it are nowhere near enough to help to justify the expectations baked into Tesla’s stock price.</p>\n<p><b>Production Capacity Growth Will Require Billions of $.</b>Current and expected production capacities of all known Tesla factories equals ~2.7 million vehicles, or 12.9 million short of the 2030 production implied by its stock price. See Figure 6.</p>\n<p>In other words, despite the new factories coming online, Tesla must spend billions and build many new manufacturing plants before it can approach the capacity needed to sell the number of cars implied by its valuation.</p>\n<p>Given the many issues in ramping production in the past, investors should not assume Tesla can increase its production by 5x without any problems.</p>\n<p><b>Figure 6: Tesla’s Pending Production Shortfall</b></p>\n<p><img src=\"https://static.tigerbbs.com/7d0c946fecb2fd037adac367c7c5b7c2\" tg-width=\"960\" tg-height=\"285\" referrerpolicy=\"no-referrer\">*Projection based on InsideEVs estimate of 600,000 vehicles per year</p>\n<p>**Optimistic assumption based on Texas being Tesla’s biggest factory and possibly the largest factory in the United States</p>\n<p><b>Incumbents Must Fail for Tesla to Meet Growth Expectations.</b>For many years now, incumbent automakers have spent billions of dollars building out their EV offerings. Automakers other than Tesla already account for 85% of global EV sales through the first half of 2021.</p>\n<p>The global EV market is simply not big enough for Tesla to achieve the sales expectations in its valuation unless nearly all of the incumbents reverse course and completely fail to sell EVs.</p>\n<p>Here are the projections from the large incumbent automakers that have provided specific goals for future EV production.</p>\n<ul>\n <li>Volkswagen Group projects that 50% of its global sales will be fully electric by 2030</li>\n <li>Stellantis projects 70% and 40% of its European and North American sales, respectively, will be fully electric by 2030</li>\n <li>Ford projects that 40% of its sales will be fully electric by 2030.</li>\n <li>Toyota projects that it will sell 2 million EVs by 2030</li>\n <li>Honda plans to sell only EVs in China by 2030</li>\n <li>BMW expects at least half its sales to be zero-emission vehicles by 2030</li>\n <li>Daimler, manufacturer of Mercedes Benz, expects half its sales to be “EV and hybrid by 2025”</li>\n <li>General Motors is targeting EV sales of “more than 1 million” by 2025</li>\n <li>Volvo plans to sell only fully electric vehicles by 2030</li>\n <li>Nissan projects 40% of U.S. sales to be EVs by 2030</li>\n</ul>\n<p>Based on these projections, I estimate how many EVs each company aims to produce[1] by 2030 and the market share implied by that production as a percentage of base-case global passenger EV sales in 2030.</p>\n<ul>\n <li>Volkswagen Group: 5.5 million, 21% market share</li>\n <li>Stellantis: 3.6 million[2], 14% market share</li>\n <li>Ford: 2.2 million, 9% market share</li>\n <li>Toyota: 2 million, 8% market share</li>\n <li>Honda (in China): 1.5 million, 6% market share</li>\n <li>BMW: 1.3 million, 5% market share</li>\n <li>Mercedes Benz: 1.2+ million, 5% market share</li>\n <li>General Motors: 1+ million, 4% market share</li>\n <li>Volvo: 700,000, 3% market share</li>\n <li>Nissan (in U.S.): 500,000, 2% market share</li>\n <li><b>Total = 19+ million vehicles and 75% market share</b></li>\n</ul>\n<p>These estimates do not include other incumbents and new entrants (e.g. Jaguar Land Rover, NIO Inc. [NIO], Rivian [RIVN], Ludic [LCID] and more) or other Chinese EV makers because I could not find specific projections for EV production. Nevertheless, I am confident that their combined market share will be more than zero.</p>\n<p>The point is that the rest of the world is not planning to stand by, give up existing market share, and let Tesla own majority of the EV market. Many very experienced and successful automakers are spending many multiples of what Tesla is spending to compete in the EV market.</p>\n<p>The bottom line is that it is hard to make a straight-faced argument that Tesla can achieve the sales implied by its valuation in a competitive market.</p>\n<p><b>Incumbents Can Afford to Spend More than Tesla.</b>Incumbents already have infrastructure to produce and sell vehicles at scale, and they are spending billions of dollars to compete in the EV market. Ford, Volkswagen, General Motors, and Stellantis alone are planning to spend at least $280 billion through 2025 and produce over 12 million EVs by 2030.</p>\n<p>Given the huge investments from multiple competitors, I expect the EV market will be extremely competitive, as manufacturers fight for profits and market share. The “winner take all” outcome implied by Tesla’s valuation is extremely unlikely. Perhaps, Bernstein analyst Toni Sacconaghi said it best, “the automotive industry is an increasingly global and hypercompetitive industry and I believe that surplus profits and technology innovation will likely be competed away over time, as has been the case historically.\" In such a market, Tesla cannot achieve the market share implied by its valuation.</p>\n<p>Unlike Tesla, the incumbents generate plenty of free cash flow (FCF) to fund their EV investments and don’t have to dilute existing shareholders to expand EV capacity as Tesla does. For instance, over the last five years, General Motors, Stellantis, and Ford generated a cumulative $12.4 billion, $7.1, and $6.1 billion in free cash flow while Tesla burned -$19.5 billion.</p>\n<p><b>FSD Continues to Overpromise And Underdeliver.</b>Full-self driving (FSD) has been consistently plagued by issues that, unfortunately, have deadly consequences. Industry research provider Guidehouse Insights ranks Tesla last in its 2021 ranking of Automated Driver Systems (ADS), and states flatly, “Tesla needs a thorough rethink of its approach to developing ADS. It has overpromised with its marketing for nearly 5 years and severely underdelivered.”</p>\n<p>Per Figure 7, Tesla lags the competition by quite a large margin, as it’s the only company that falls into the \"Followers\" category.</p>\n<p>The most recent problems with Tesla’s FSD version 10.3 forced the company to roll back the update as users reported false crash warnings and other problems with autosteer and cruise control. These issues resulted in Tesla recalling nearly 12,000 vehicles because “a communication error may cause a false forward-collision warning or unexpected activation of the emergency brakes,” according to the National Highway Traffic Safety Administration (NHTSA).</p>\n<p>While the roll out of an updated 10.3.1 has restarted, Tesla’s haphazard approach to deploying FSD remains unsettling and led Guidehouse Insights to note, “Tesla’s approach to testing its system is fundamentally at odds with virtually every other company in this industry.”</p>\n<p><b>Figure 7: Tesla Ranks Last Amongst Automated Driver Systems</b></p>\n<p><img src=\"https://static.tigerbbs.com/6ddd92d3ed67347fa0741599f91ce31d\" tg-width=\"919\" tg-height=\"739\" width=\"100%\" height=\"auto\"></p>\n<p>Alphabet’s Waymo routinely ranks as the best automated driving system. Importantly, many of the firms ranked ahead of Tesla are focused solely on building automated driving systems and are not distracted by scaling up automobile production, delivery logistics, and the general day-to-day operations of producing cars. Even so, other direct competitors such as GM Super Cruise also get better scores from third-party organizations.</p>\n<p><b>Increased Regulatory Risk.</b>While Tesla has mysteriously avoided regulatory crackdown on its sales of FSD and practice of beta testing software on live drivers and roads, renewed requests from the NHTSA/National Transportation Safety Board (NTSB) signal that Tesla might be held accountable for practices that many find highly misleading and dangerous to citizens.</p>\n<p>Missy Cummings, recently appointed as senior advisor for safety at the NHTSA, has expressed concerns about Tesla’s FSD in the past, tweeting as far back as 2019 that Tesla’s “autopilot easily cause mode confusion, is unreliable and unsafe” and that “NHTSA should require Tesla turn it off.”</p>\n<p>More recently, Tesla requested “confidential business information treatment” on its responses to a litany of information requests the NHTSA made as part of its investigation into FSD. If approved, the public would likely never see Tesla’s responses to key questions pertaining to Tesla not issuing a recall for Autopilot after multiple accidents involving parked emergency vehicles, the selection criteria for Tesla’s FSD beta testing program, and the non-disclosure agreements Tesla was making drivers sign before they could use the beta system.</p>\n<p>The NHTSA is not alone in criticizing Tesla and its FSD rollout. On October 26, 2021, the head of the U.S. NTSB, Jennifer Homendy, said that Tesla has not yet officially responded to the NTSB regarding its safety recommendations while calling the use of full self-driving ”misleading.” She stated, “my biggest concern is that Tesla is rolling out full self-driving technology in beta on city streets with untrained drivers and they have not addressed our recommendations that we’ve issued as a result of numerous investigations of Tesla crashes.”</p>\n<p><b>Battery Technologies Are Nothing Special.</b>Tesla announced it will be switching to a lithium iron phosphate (LFP) battery in all standard range cars. These batteries are already being used in vehicles built in the Shanghai factory, and this switch is expected to bring down costs. The timing of this change comes as other battery producers, in partnership with incumbent auto manufacturers, are ramping up production, which should drive down battery costs for all EV makers. In other words, the competitive advantages of a cheaper battery may be short-lived, as incumbents build economies of scale in their own supply chain in the coming years.</p>\n<p>Additionally, while the much heralded 4680 cylindrical battery, produced by Panasonic for Tesla, and nearly ready for production, should bring a higher energy density in a more efficient package, competitors’ offerings all aim to provide the same.</p>\n<p>General Motor’s Ultium platform will enable up to 400-450 miles of range, and the firm is building a new battery research facility aimed at building batteries capable of 600 miles on a single charge. General Motors recently announced a joint venture with LG Chem to build a second U.S. battery cell plant, which is expected to have an annual capacity of 35 gigawatt hours, or slightly above the 30 gigawatt hour capacity of its first Lordstown battery plant. Morgan Stanley analyst Adam Jonas noted that the “formation of Ultium/Ultium Cells LLC will prove to be a critical point of strategic differentiation that will ultimately drive value creation for [GM] shareholders.”</p>\n<p>Ford’s Mustang Mach-E became the first electric SUV not made by Tesla to reach an EPA-rated range of up to 300 miles, and the company recently entered a partnership with SK Innovation to build three U.S.-based battery plants to power 1 million EVs annually.</p>\n<p>On its own, LG Chem plans to expand its existing U.S. facilities and build two more plants that will produce both pouch cells used by General Motors, Ford, Jaguar, Audi, Porsche, and more, as well as the cylindrical cells used by Tesla.</p>\n<p>Ultimately, the race for the “perfect” battery is less important than the race to procure battery supplies to build the number of EVs each manufacturer aims to produce in the coming years. The incumbents have proven they can maintain and win a race to procure supplies, and they’ve only been doing it for multiple decades now.</p>\n<p><b>Not All Supply Issues Can Be Coded Away.</b>To its credit, Tesla managed the global chip shortage relatively well by re-writing software to allow the use of alternative chips. However, not all supply issues can be solved via software, as evidenced by the growing wait times for Tesla’s vehicles. As Electrek notes, Tesla recently updated its delivery timelines for new orders, and depending upon specs, some vehicles won’t be delivered until September 2022 if ordered today. New orders for the Model 3 Standard Range Plus, which is Tesla’s cheapest vehicle, are currently on pace to be delivered in May 2022, or seven months from now.</p>\n<p>While certainly not unique to Tesla, extended delivery/wait times give consumers ample time to comparison shop and possibly switch orders to a competitor’s EV that would be available sooner.</p>\n<p>Delivery delays aren’t exclusive to in-production vehicles, but Tesla’s future vehicles as well. The much-hyped Cybertruck has recently been delayed again, this time until at least 2023 (compared to an original late 2021 release), which ultimately gives competitors more time to establish a presence in the EV truck market. I recently outlined the many competitors in the EV truck market in my report on Rivian.</p>\n<p><b>Putting It All Together: Tesla Provides Poor Risk/Reward</b></p>\n<p>Given the challenges ahead for Tesla, coupled with a valuation that implies it will take 60%+ of the global EV market share, I think it is clear: Tesla’s stock offers poor risk/reward.</p>\n<p>Tesla has proven risky to short, but investors need not buy shares today at such an elevated price.</p>\n<p>If you’re buying Tesla at its current valuation, you’re not only betting that it will be the only winner of the electrification of the global automotive fleet, but that it will somehow be twice as profitable as Toyota and achieve at least 60% market share. With anything less than total market domination, TSLA presents large downside risk.</p>","source":"fors","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla: $1 Trillion Of Speculation</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla: $1 Trillion Of Speculation\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-12 22:10 GMT+8 <a href=https://www.forbes.com/sites/greatspeculations/2021/11/09/tesla-1-trillion-of-speculation/?sh=34ca1f2f77eb><strong>Forbes</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Tesla’s (TSLA) market cap surpassed the trillion-dollar mark, driven by a post-earnings rally that got a boost from the announcement of a 100,000-vehicle order from Hertz (HTZ), which might not even ...</p>\n\n<a href=\"https://www.forbes.com/sites/greatspeculations/2021/11/09/tesla-1-trillion-of-speculation/?sh=34ca1f2f77eb\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"https://www.forbes.com/sites/greatspeculations/2021/11/09/tesla-1-trillion-of-speculation/?sh=34ca1f2f77eb","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1163118124","content_text":"Tesla’s (TSLA) market cap surpassed the trillion-dollar mark, driven by a post-earnings rally that got a boost from the announcement of a 100,000-vehicle order from Hertz (HTZ), which might not even happen.\nEven if it does come to pass, the Hertz order is a drop in the bucket of growth expectations baked into Tesla’s valuation. Tesla needs 155 Hertz-sized orders to justify the revenue expectations in its stock price. Put another way, the $1.2 trillion valuation implies Tesla owns 60%+ of the entire global passenger EV market and becomes more profitable than Apple (AAPL) by 2030.\nThis report provides objective perspective on how outrageously high the valuation of Tesla stock is and the clear impracticality of the company meeting the expectations baked into its valuation.\nTesla’s Valuation vs. Competitors Makes No Sense\nTesla’s market cap is now greater than the next 10 largest (ranked by market cap) auto manufacturers combined.\nFigure 1: Tesla’s Market Cap Vs. Competitors\n\nThis valuation comes despite Tesla selling less than 1/50th of the vehicles than the combined total sold by the next 10 largest automakers over the trailing twelve months ended the first half of 2021. See Figure 2.\nI cannot conceive of a straight-faced argument for the disconnect between Tesla’s valuation and its vehicle sales compared to its competitors.\nFigure 2: Tesla’s Car Sales Vs. Competitors\n* Stellantis sales estimated as Fiat Chrysler and PSA Group’s 2H20 sales and Stellantis’ 1H21 sales. Stellantis was formed as a merger between the two in January 2021.\nIs the Hertz Deal Really Worth $100 Billion+ in Market Cap?\nEven if Hertz eventually agrees to buy 100,000 Tesla Model 3s, I do not think it is worth the $100 billion in market cap, or $1 million per vehicle, that we saw investors give Tesla’s market cap after the Hertz deal made headlines. Even Elon Musk questioned the surge in share price, noting that the price movement was “strange” given that Tesla is “very much a production ramp problem, not a demand problem.”\nThis $100 billion market cap jump makes even less sense in the context of Tesla’s sky-high valuation before the announcement. Clearly, the feasibility of Tesla meeting the sales expectations embedded in its market cap plays no role in its valuation. For those that do care about expectations investing, I did the math and Tesla needs to successfully deliver on 155 Hertz-sized deals to meet the sales implied by a $1.2 trillion market cap.\nWill the Hertz Deal Result in Any Profits – If It Goes Through?\nAfter Elon Musk tweeted on November 1, 2021 that “no contract has been signed yet”, the Hertz deal reminds me of another famous tweet: \"am considering taking Tesla private at $420. Funding secured.”\nEven if the deal does go through, the pricing terms are very unclear. Elon insists that no cars will be sold at a discount. Meanwhile, Hertz CEO Mark Fields has made it clear that he is playing the field and working on getting cars from all EV manufacturers on his lot.\nEither Tesla is selling cars at a (large or small) discount, the deal terms are wrong, or the deal does not get done. If the deal gets done, I do not expect it to be profitable. Rental car companies are accustomed to getting discounts for bulk orders, and I see no reason for Hertz to expect to pay list prices on a deal for so many cars.\nAt the end of the day, I’m not sure pricing matters because I don't think the Hertz deal gets done. This affair is more about headlines and fueling speculation than doing any real business.\nTesla’s Global Market Share Getting Smaller\nTesla’s first-mover is already eroding, and its market share continues to decline. In the first half of 2021, Tesla sold 14.6% of the EVs sold worldwide compared to 18.8% over the same period in 2020.\nRising volumes, and falling market share are to be expected in a nascent industry. The problem is that Tesla’s isn’t priced for declining market share. It is priced for massive market share gains, unheard of gains in nearly any industry across the globe, especially in an industry as large and competitive as passenger vehicles.\nReverse DCF Math: Valuation Implies Tesla Will Own 60%+ of the Global Passenger EV Market\nAt its current average selling price (ASP) of ~$51k, Tesla’s stock price of ~1,200/share implies the firm will sell 16 million vehicles in 2030 (versus ~800k TTM), or 60% of the projected base case global EV passenger vehicle market in 2030. For reference, Adam Jonas, a Morgan Stanley analyst with a price target of $1,600/share, projects Tesla will sell 8.1 million vehicles in 2030.\nI think it is unlikely that Tesla will sell such a high volume of vehicles at a $51k ASP, yet the implied vehicle sales based on lower ASPs look even more impractical.\nAs detailed in the next section, this analysis assumes Tesla achieves profit margins twice as high as Toyota (TM) and quadruples its current auto manufacturing efficiency. In other words, I aim to provide inarguably best-case scenarios for assessing the expectations reflected in Tesla’s stock price.\nPer Figure 3, Tesla’s current valuation implies that, in 2030, it will sell the following number of vehicles based on these ASP benchmarks:\n\n16 million vehicles – current ASP of $51k\n21 million vehicles – ASP of $38k (average new car price in the U.S. in 2020)\n46 million vehicles – ASP of $17k (equal to General Motors over the TTM)\n\nIf Tesla achieves those EV sales, the implied market share for the company would be the following (assuming global passenger EV sales reach 25.8 million in 2030, the base case projection from the IEA):\n\n60% for 16 million vehicles\n80% for 21 million vehicles\n179% for 46 million vehicles\n\nIf I assume the IEA’s best case for global passenger EV sales in 2030, 46.8 million vehicles, the above vehicle sales represent:\n\n33% for 16 million vehicles\n44% for 21 million vehicles\n98% for 46 million vehicles\n\nFigure 3: Tesla’s Implied Vehicle Sales in 2030 to Justify Current Valuation\nThe Math Shows that Tesla Must be More Profitable Than Apple\nHere are the assumptions I use in my reverse discounted cash flow (DCF) model to calculate the implied production levels above.\nTo justify its current price of ~$1,200/share, Tesla must:\n\nimmediately achieve a 17.2% NOPAT margin (double Toyota’s margin, which is the highest of the large-scale automakers I cover), compared to Tesla’s TTM margin of 7.7%) and\ngrow revenue by 38% compounded annually for the next decade.\n\nIn this scenario, Tesla generates $783 billion in revenue in 2030, which is 102% of the combined revenues of Toyota, General Motors, Ford (F), Honda Motor Corp (HMC), and Stellantis (STLA) over the TTM.\nThis scenario also implies Tesla generates $135 billion in net operating profit after-tax (NOPAT) in 2030, or 45% higher than Apple’s (AAPL) TTM NOPAT, which, at $93 billion, is the highest of all companies my firm covers.\nTSLA Has 60%+ Downside If Morgan Stanley Is Right About Sales\nIf I assume Tesla reaches Morgan Stanley’s estimate of selling 8.1 million cars in 2030 (which implies a 31% share of the global passenger EV market in 2030), at an ASP of $38k, the stock is worth just $483/share. Details:\n\nNOPAT margin improves to 17.2% and\nrevenue grows 27% compounded annually over the next decade, then\n\nthe stock is worth just $483/share today – 60% downside to the current price. See the math behind this reverse DCF scenario. In this scenario, Tesla grows NOPAT to $60 billion, or nearly 17x its TTM NOPAT, and just 3% below Alphabet’s (GOOGL) TTM NOPAT.\nTSLA Has 88%+ Downside Even with 28% Market Share and Realistic Margins\nIf I estimate more reasonable (but still very optimistic) margins and market share achievements for Tesla, the stock is worth just $148/share. Here’s the math:\n\nNOPAT margin improves to 8.5% (equal to General Motors’ TTM margin, compared to Tesla’s TTM margin of 7.7%) and\nrevenue grows by consensus estimates from 2021-2023 and\nrevenue grows 18% a year from 2024-2030, then\n\nthe stock is worth just $148/share today – an 88% downside to the current price.\nIn this scenario, Tesla sells 7.2 million cars (at an ASP of 38k) and owns 28% of the global passenger EV market in 2030. If Tesla fails to meet these expectations, then the stock is worth less than $148/share.\nAlso, for this scenario, I assume a much more realistic NOPAT margin, 8.5%, for Tesla. Given the expansion required of the business, struggles to be profitable to date, and formidable competition, I think Tesla will be lucky to achieve and sustain a margin as high as 8.5% from 2021-2030.\nFigure 4 compares the firm’s historical NOPAT to the NOPAT implied by its current stock price, the 8.1 million vehicle sales scenario, and the 7.2 million vehicle sales scenario to illustrate just how high the expectations baked into Tesla’s stock price remain. For additional context, I show Toyota’s, General Motors’, and Apple’s TTM NOPAT.\nFigure 4: Tesla’s Historical and Implied NOPAT: DCF Valuation Scenarios\n\nEach of the above scenarios assumes Tesla’s invested capital grows 14% compounded annually through 2030. For reference, Tesla’s invested capital grew 53% compounded annually from 2010-2020 and 29% compounded annually from 2015-2020. Invested capital at the end of 3Q21 grew 21% YoY. Tesla’s property, plant, and equipment has grown even faster, at 58% compounded annually, since 2010.\nA 14% CAGR represents 1/4th the CAGR of Tesla’s property, plant, and equipment since 2010 and assumes the company can build future plants and produce cars 4x more efficiently than it has so far.\nIn other words, I aim to provide inarguably best-case scenarios for assessing the expectations for future market share and profits reflected in Tesla’s stock market valuation.\nWhy Tesla’s $1 Trillion Valuation Is Ridiculous\nNow that I’ve shown how high the expectations baked into Tesla’s valuation are, I’ll present some of the many challenges Tesla faces to meet those expectations.\nTesla Remains “Just” a Car Company, Despite Bulls’ Arguments Otherwise.One of the most common arguments bulls make to justify Tesla’s valuation is that the company is more than just a car company. Instead, the argument goes: Tesla is a software, tech, insurance, energy, transportation, “insert any other blank” company. However, the financials bear out a different picture and show the other businesses are more hype than substance. At this point, Tesla is a only car company and generates the entirety of its profits from vehicles.\nPer Figure 5, Tesla generated 88% of revenue from Automotive Sales in 3Q21, which is up from 87% in 3Q20, and above the quarterly average of 86% since 3Q19. For reference, automotive sales made up 87% and 93% of General Motors’ and Ford’s 3Q21 revenue respectively.\nFigure 5: Tesla’s Revenue Breakdown: 3Q19 – 3Q21\nTesla’s two other segments, Energy generation and storage and Services and other, which make up 12% of revenue in 3Q21, are unprofitable. Over the TTM, Tesla generated $10.8 billion in gross profit. $11.2 billion came from its Automotive segment while Energy generation and storage and Services and other racked up gross losses of $113 million and $263 million. Despite many claims and promises to the contrary over the years, Tesla doesn’t generate gross profit doing anything but selling cars.\nInsurance Business Is Not Material. Tesla bulls will also point to Tesla’s insurance business as another way to drive profit growth. I’ve previously covered how Tesla insurance does not have the competitive advantages that bulls ascribe to it and has a long way to go before it can get meaningfully off the ground.\nEven if Tesla’s insurance business gets off the ground, I would not expect it to make much money. For example, from 2004-2006, General Motors generated about $70 per car sold in GAAP net income from its insurance business. If I assume Tesla can generate the same level of business, Tesla insurance would result in just $57 million in GAAP net income based on TTM vehicles sold.\nBulls will counter that Tesla will be so much better at insurance than GM and that GM is not a good comp. There is no way to know for sure. Nevertheless, I concede that anything is possible, but the likelihood of Tesla’s insurance business being material profit producer is extremely low.\nRegardless of how successful Tesla insurance is, the potential profits from it are nowhere near enough to help to justify the expectations baked into Tesla’s stock price.\nProduction Capacity Growth Will Require Billions of $.Current and expected production capacities of all known Tesla factories equals ~2.7 million vehicles, or 12.9 million short of the 2030 production implied by its stock price. See Figure 6.\nIn other words, despite the new factories coming online, Tesla must spend billions and build many new manufacturing plants before it can approach the capacity needed to sell the number of cars implied by its valuation.\nGiven the many issues in ramping production in the past, investors should not assume Tesla can increase its production by 5x without any problems.\nFigure 6: Tesla’s Pending Production Shortfall\n*Projection based on InsideEVs estimate of 600,000 vehicles per year\n**Optimistic assumption based on Texas being Tesla’s biggest factory and possibly the largest factory in the United States\nIncumbents Must Fail for Tesla to Meet Growth Expectations.For many years now, incumbent automakers have spent billions of dollars building out their EV offerings. Automakers other than Tesla already account for 85% of global EV sales through the first half of 2021.\nThe global EV market is simply not big enough for Tesla to achieve the sales expectations in its valuation unless nearly all of the incumbents reverse course and completely fail to sell EVs.\nHere are the projections from the large incumbent automakers that have provided specific goals for future EV production.\n\nVolkswagen Group projects that 50% of its global sales will be fully electric by 2030\nStellantis projects 70% and 40% of its European and North American sales, respectively, will be fully electric by 2030\nFord projects that 40% of its sales will be fully electric by 2030.\nToyota projects that it will sell 2 million EVs by 2030\nHonda plans to sell only EVs in China by 2030\nBMW expects at least half its sales to be zero-emission vehicles by 2030\nDaimler, manufacturer of Mercedes Benz, expects half its sales to be “EV and hybrid by 2025”\nGeneral Motors is targeting EV sales of “more than 1 million” by 2025\nVolvo plans to sell only fully electric vehicles by 2030\nNissan projects 40% of U.S. sales to be EVs by 2030\n\nBased on these projections, I estimate how many EVs each company aims to produce[1] by 2030 and the market share implied by that production as a percentage of base-case global passenger EV sales in 2030.\n\nVolkswagen Group: 5.5 million, 21% market share\nStellantis: 3.6 million[2], 14% market share\nFord: 2.2 million, 9% market share\nToyota: 2 million, 8% market share\nHonda (in China): 1.5 million, 6% market share\nBMW: 1.3 million, 5% market share\nMercedes Benz: 1.2+ million, 5% market share\nGeneral Motors: 1+ million, 4% market share\nVolvo: 700,000, 3% market share\nNissan (in U.S.): 500,000, 2% market share\nTotal = 19+ million vehicles and 75% market share\n\nThese estimates do not include other incumbents and new entrants (e.g. Jaguar Land Rover, NIO Inc. [NIO], Rivian [RIVN], Ludic [LCID] and more) or other Chinese EV makers because I could not find specific projections for EV production. Nevertheless, I am confident that their combined market share will be more than zero.\nThe point is that the rest of the world is not planning to stand by, give up existing market share, and let Tesla own majority of the EV market. Many very experienced and successful automakers are spending many multiples of what Tesla is spending to compete in the EV market.\nThe bottom line is that it is hard to make a straight-faced argument that Tesla can achieve the sales implied by its valuation in a competitive market.\nIncumbents Can Afford to Spend More than Tesla.Incumbents already have infrastructure to produce and sell vehicles at scale, and they are spending billions of dollars to compete in the EV market. Ford, Volkswagen, General Motors, and Stellantis alone are planning to spend at least $280 billion through 2025 and produce over 12 million EVs by 2030.\nGiven the huge investments from multiple competitors, I expect the EV market will be extremely competitive, as manufacturers fight for profits and market share. The “winner take all” outcome implied by Tesla’s valuation is extremely unlikely. Perhaps, Bernstein analyst Toni Sacconaghi said it best, “the automotive industry is an increasingly global and hypercompetitive industry and I believe that surplus profits and technology innovation will likely be competed away over time, as has been the case historically.\" In such a market, Tesla cannot achieve the market share implied by its valuation.\nUnlike Tesla, the incumbents generate plenty of free cash flow (FCF) to fund their EV investments and don’t have to dilute existing shareholders to expand EV capacity as Tesla does. For instance, over the last five years, General Motors, Stellantis, and Ford generated a cumulative $12.4 billion, $7.1, and $6.1 billion in free cash flow while Tesla burned -$19.5 billion.\nFSD Continues to Overpromise And Underdeliver.Full-self driving (FSD) has been consistently plagued by issues that, unfortunately, have deadly consequences. Industry research provider Guidehouse Insights ranks Tesla last in its 2021 ranking of Automated Driver Systems (ADS), and states flatly, “Tesla needs a thorough rethink of its approach to developing ADS. It has overpromised with its marketing for nearly 5 years and severely underdelivered.”\nPer Figure 7, Tesla lags the competition by quite a large margin, as it’s the only company that falls into the \"Followers\" category.\nThe most recent problems with Tesla’s FSD version 10.3 forced the company to roll back the update as users reported false crash warnings and other problems with autosteer and cruise control. These issues resulted in Tesla recalling nearly 12,000 vehicles because “a communication error may cause a false forward-collision warning or unexpected activation of the emergency brakes,” according to the National Highway Traffic Safety Administration (NHTSA).\nWhile the roll out of an updated 10.3.1 has restarted, Tesla’s haphazard approach to deploying FSD remains unsettling and led Guidehouse Insights to note, “Tesla’s approach to testing its system is fundamentally at odds with virtually every other company in this industry.”\nFigure 7: Tesla Ranks Last Amongst Automated Driver Systems\n\nAlphabet’s Waymo routinely ranks as the best automated driving system. Importantly, many of the firms ranked ahead of Tesla are focused solely on building automated driving systems and are not distracted by scaling up automobile production, delivery logistics, and the general day-to-day operations of producing cars. Even so, other direct competitors such as GM Super Cruise also get better scores from third-party organizations.\nIncreased Regulatory Risk.While Tesla has mysteriously avoided regulatory crackdown on its sales of FSD and practice of beta testing software on live drivers and roads, renewed requests from the NHTSA/National Transportation Safety Board (NTSB) signal that Tesla might be held accountable for practices that many find highly misleading and dangerous to citizens.\nMissy Cummings, recently appointed as senior advisor for safety at the NHTSA, has expressed concerns about Tesla’s FSD in the past, tweeting as far back as 2019 that Tesla’s “autopilot easily cause mode confusion, is unreliable and unsafe” and that “NHTSA should require Tesla turn it off.”\nMore recently, Tesla requested “confidential business information treatment” on its responses to a litany of information requests the NHTSA made as part of its investigation into FSD. If approved, the public would likely never see Tesla’s responses to key questions pertaining to Tesla not issuing a recall for Autopilot after multiple accidents involving parked emergency vehicles, the selection criteria for Tesla’s FSD beta testing program, and the non-disclosure agreements Tesla was making drivers sign before they could use the beta system.\nThe NHTSA is not alone in criticizing Tesla and its FSD rollout. On October 26, 2021, the head of the U.S. NTSB, Jennifer Homendy, said that Tesla has not yet officially responded to the NTSB regarding its safety recommendations while calling the use of full self-driving ”misleading.” She stated, “my biggest concern is that Tesla is rolling out full self-driving technology in beta on city streets with untrained drivers and they have not addressed our recommendations that we’ve issued as a result of numerous investigations of Tesla crashes.”\nBattery Technologies Are Nothing Special.Tesla announced it will be switching to a lithium iron phosphate (LFP) battery in all standard range cars. These batteries are already being used in vehicles built in the Shanghai factory, and this switch is expected to bring down costs. The timing of this change comes as other battery producers, in partnership with incumbent auto manufacturers, are ramping up production, which should drive down battery costs for all EV makers. In other words, the competitive advantages of a cheaper battery may be short-lived, as incumbents build economies of scale in their own supply chain in the coming years.\nAdditionally, while the much heralded 4680 cylindrical battery, produced by Panasonic for Tesla, and nearly ready for production, should bring a higher energy density in a more efficient package, competitors’ offerings all aim to provide the same.\nGeneral Motor’s Ultium platform will enable up to 400-450 miles of range, and the firm is building a new battery research facility aimed at building batteries capable of 600 miles on a single charge. General Motors recently announced a joint venture with LG Chem to build a second U.S. battery cell plant, which is expected to have an annual capacity of 35 gigawatt hours, or slightly above the 30 gigawatt hour capacity of its first Lordstown battery plant. Morgan Stanley analyst Adam Jonas noted that the “formation of Ultium/Ultium Cells LLC will prove to be a critical point of strategic differentiation that will ultimately drive value creation for [GM] shareholders.”\nFord’s Mustang Mach-E became the first electric SUV not made by Tesla to reach an EPA-rated range of up to 300 miles, and the company recently entered a partnership with SK Innovation to build three U.S.-based battery plants to power 1 million EVs annually.\nOn its own, LG Chem plans to expand its existing U.S. facilities and build two more plants that will produce both pouch cells used by General Motors, Ford, Jaguar, Audi, Porsche, and more, as well as the cylindrical cells used by Tesla.\nUltimately, the race for the “perfect” battery is less important than the race to procure battery supplies to build the number of EVs each manufacturer aims to produce in the coming years. The incumbents have proven they can maintain and win a race to procure supplies, and they’ve only been doing it for multiple decades now.\nNot All Supply Issues Can Be Coded Away.To its credit, Tesla managed the global chip shortage relatively well by re-writing software to allow the use of alternative chips. However, not all supply issues can be solved via software, as evidenced by the growing wait times for Tesla’s vehicles. As Electrek notes, Tesla recently updated its delivery timelines for new orders, and depending upon specs, some vehicles won’t be delivered until September 2022 if ordered today. New orders for the Model 3 Standard Range Plus, which is Tesla’s cheapest vehicle, are currently on pace to be delivered in May 2022, or seven months from now.\nWhile certainly not unique to Tesla, extended delivery/wait times give consumers ample time to comparison shop and possibly switch orders to a competitor’s EV that would be available sooner.\nDelivery delays aren’t exclusive to in-production vehicles, but Tesla’s future vehicles as well. The much-hyped Cybertruck has recently been delayed again, this time until at least 2023 (compared to an original late 2021 release), which ultimately gives competitors more time to establish a presence in the EV truck market. I recently outlined the many competitors in the EV truck market in my report on Rivian.\nPutting It All Together: Tesla Provides Poor Risk/Reward\nGiven the challenges ahead for Tesla, coupled with a valuation that implies it will take 60%+ of the global EV market share, I think it is clear: Tesla’s stock offers poor risk/reward.\nTesla has proven risky to short, but investors need not buy shares today at such an elevated price.\nIf you’re buying Tesla at its current valuation, you’re not only betting that it will be the only winner of the electrification of the global automotive fleet, but that it will somehow be twice as profitable as Toyota and achieve at least 60% market share. With anything less than total market domination, TSLA presents large downside risk.","news_type":1},"isVote":1,"tweetType":1,"viewCount":430,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":846639400,"gmtCreate":1636076692627,"gmtModify":1636076692792,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087463284623270","idStr":"4087463284623270"},"themes":[],"htmlText":"Okayy","listText":"Okayy","text":"Okayy","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/846639400","repostId":"1155962755","repostType":4,"isVote":1,"tweetType":1,"viewCount":89,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":854420468,"gmtCreate":1635474820167,"gmtModify":1635474820233,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087463284623270","idStr":"4087463284623270"},"themes":[],"htmlText":"okay ","listText":"okay ","text":"okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/854420468","repostId":"1116236143","repostType":4,"isVote":1,"tweetType":1,"viewCount":113,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691559816,"gmtCreate":1640223175185,"gmtModify":1640223175185,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087463284623270","idStr":"4087463284623270"},"themes":[],"htmlText":"[Smile] ","listText":"[Smile] ","text":"[Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691559816","repostId":"1183786099","repostType":2,"repost":{"id":"1183786099","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据,旨在帮助投资者理解世界,做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1640217398,"share":"https://www.laohu8.com/m/news/1183786099?lang=&edition=full","pubTime":"2021-12-23 07:56","market":"hk","language":"zh","title":"昨夜今晨:美股指两连涨!特斯拉大涨超7%","url":"https://stock-news.laohu8.com/highlight/detail?id=1183786099","media":"老虎资讯综合","summary":"摘要:①纳指涨1.18%,新能源汽车股表现强势,特斯拉大涨7.5%;\n\n\n ②美国三季度实际GDP年化季环比终值 2.3%,较二季度增速大幅放缓;\n\n\n ③供应链称苹果首款电动车Apple Car将于","content":"<blockquote>\n 摘要:①纳指涨1.18%,新能源汽车股表现强势,特斯拉大涨7.5%;\n</blockquote>\n<blockquote>\n ②美国三季度实际GDP年化季环比终值 2.3%,较二季度增速大幅放缓;\n</blockquote>\n<blockquote>\n ③供应链称苹果首款电动车Apple Car将于明年9月发布。\n</blockquote>\n<p></p>\n<p><b>海外市场</b></p>\n<p>1、美股指两连涨!纳指涨超1% 特斯拉大涨7.5%</p>\n<p>美股三大指数集体收涨,主要股指连续第二个交易日反弹。美国总统拜登督促民众接种加强针,并表示不会恢复疫情爆发初期实施的严格封锁措施。美国第三季度GDP增长2.3%,好于市场预期。截至收盘,纳斯达克指数涨1.18%,标普500指数涨1.02%,道琼斯指数涨0.74%。</p>\n<p>新能源汽车股表现强势,SonoGroup涨近14%;特斯拉收涨7.5%,创11月1日以来最大单日涨幅,市值当日暴增706.21亿美元(约合人民币4498亿元)。</p>\n<p>小鹏汽车涨超4%,理想汽车涨1.4%。大型科技股集体走高,苹果涨1.53%,亚马逊涨0.36%,Meta跌1.12%,谷歌涨2.05%,微软涨1.81%,奈飞涨1.54%。</p>\n<p>2、热门中概股多数收跌 阿里跌超4%</p>\n<p>阿里巴巴跌超4%,此前阿里云被暂停作为工信部网络安全威胁信息共享平台合作单位</p>\n<p>其他中概股方面,雾芯科技涨超2%,京东微涨;贝壳收平,百度跌近1%,金山云、新东方跌超1%,滴滴跌超6%,好未来跌超3%,搜狐跌超2%。</p>\n<p>3、欧股主要指数上涨,法国CAC40指数涨超1%</p>\n<p>德国DAX30指数收涨0.91%,英国富时100指数涨0.60%,法国CAC40指数涨1.24%,欧洲斯托克50指数涨1.00%。</p>\n<p>4、原油库存降幅超预期 美油收高2.3%</p>\n<p>因美国能源信息署(EIA)报告称美国原油库存降幅超出预期,令油价得到支撑。最终,纽约商品交易所2月交割的西德克萨斯中质原油(WTI)期货价格上涨1.64美元,涨幅为2.3%,收于每桶72.76美元。</p>\n<p>5、黄金期货收高0.8% 站上1800美元关口</p>\n<p>最近黄金期货多次测试1800美元关口,但未能长时间维持在其上方。但在周三,美元走软和美国国债收益率低迷,帮助金价站上这一关口。</p>\n<p>最终,纽约商品交易所2月交割的黄金期货价格上涨13.50美元,涨幅为0.8%,收于每盎司1802.20美元。</p>\n<p>6、土耳其股市连续4个交易日收跌 22日触发一次熔断</p>\n<p>当地时间22日,土耳其伊斯坦布尔100指数开盘报1.832.14点,较前一日收盘下跌3.14%。当地时间14时39分,股指下跌超5%,触发熔断。随后股指持续震荡,当天收盘时跌幅为4.64%。这是土耳其股市连续第四个交易日收跌。</p>\n<p>分析人士指出,土耳其财政和货币政策的不可预测性,让投资者信心受到影响,在这种情况下,很多投资者可能会选择撤离观望。</p>\n<p>由于总统埃尔多安推动货币宽松政策,土耳其央行9月以来已经累计下调基准利率500个基点,而每次下调都使得里拉进一步贬值,和年初相比,里拉跌幅曾一度超过55%。</p>\n<p><b>国际宏观</b></p>\n<p>1、拜登声称假日季供应链危机已避免 呼吁通过重建更美好未来法案</p>\n<p>美国总统乔·拜登表示,他的政府与工会和企业一起成功避免了假日季节的供应链危机。</p>\n<p>“今年秋天的时候,我们听到很多关于供应链问题的可怕警告,声称假日前后会出现危机,”拜登在白宫说。 “所以我们采取了行动。我们召集了商界和劳工界的领袖来解决问题。这场被预测很可能发生的危机并未出现。”</p>\n<p>2、美国三季度实际GDP年化季环比终值 2.3%,较二季度增速大幅放缓</p>\n<p>美国三季度实际GDP年化季环比终值 2.3%,预期 2.1%,前值 2.1%,是自2020年第二季度以来的最低增速。三季度增长放缓主要是由于全球供应链紧张导致供应短缺,以及政府向企业、家庭、和地方政府提供的疫情支持资金减少。</p>\n<p>3、美国三季度核心PCE物价指数创近30年新高 符合预期</p>\n<p>12月22日周三,据美国商务部统计,美国第三季度核心PCE物价指数年化季环比终值上涨4.6%,略高于4.5%的前值和预期;同比终值上升3.6%,与预期持平,仍是近30年最高水平。</p>\n<p>4、今年美国IPO发行量创下历史纪录 但回报率差强人意</p>\n<p>根据彭博汇编的数据,今年481宗美国IPO中有一半以上的交易价格低于发行价。这些交易,不包括更多的特殊目的收购公司,总共创下了约1670亿美元的记录,轻松超越2020年。</p>\n<p>尽管发行金额创下历史新高,但由于波动性和表现不佳,对IPO的热情在年底有所减弱。交易商表示,尽管2022年第一季看起来将十分忙录,但预计未来一年会较为波动。</p>\n<p>5、美国11月二手房销量连续第三个月增长</p>\n<p>美国全国地产经纪商协会周三公布的数据显示,11月二手房销量环比增长1.9%,折合年率达646万套,创下1月以来最大增幅。彭博调查预估中值为6.53万套。</p>\n<p>该数据表明住房需求正在加速上升,尤其是在高端市场,因为贷款成本仍远低于新冠疫情前的水平。即便如此,高房价也可能使一些潜在买家望而却步,尤其是收入水平较低、受通胀打击更大的消费者。</p>\n<p>6、美国12月消费者信心指数上升 克服了Omicron带来的恐慌</p>\n<p>世界大型企业研究会周三的报告显示,消费者信心指数升至115.8,11月数据被向上修正为111.9。接受彭博调查的经济学家预期为111。</p>\n<p>数据显示,尽管随着omicron的传播,美国一些地区实施了新的防疫限制措施,但消费者心态仍乐观。美联储主席鲍威尔和多位经济学家表示,随着美国人对新冠病毒及其变异株的适应性增强,每一波疫情带来的经济影响会变得较小。</p>\n<p>7、世卫组织正在确定第二代新冠疫苗</p>\n<p>世卫组织总干事谭德塞在22日的新闻发布会上透露,世卫组织正在通过疫苗“团结试验”确定第二代新冠疫苗。</p>\n<p>谭德塞表示,相关研究团队于9月下旬开始招募志愿者,到目前为止,已有超过11500人参加了试验。截至目前,该试验包括两种疫苗,另外三种疫苗不久将被纳入,而且还可能纳入更多的疫苗。世卫组织邀请所有国家和研究中心参与这项试验。</p>\n<p>8、美国政府宣布将学生贷款偿还期限延至明年5月1日</p>\n<p>当地时间22日,美国白宫新闻秘书珍·普萨基在简报会上证实,拜登已经宣布将学生贷款的偿还期限延长90天,到明年的5月1日。普萨基说,部分学生贷款的借款人受到新冠肺炎疫情的影响,需要时间偿还。</p>\n<p>9、欧洲能源告急!天然气狂飙新高 英国企业称正处国家危机 意大利总理高呼需紧急行动</p>\n<p>天然气暴涨也让欧洲国家坐不住了。本周三,意大利总理德拉吉在年末新闻发布会上表示,遏制能源短缺亟需采取紧急政策行动:“能源价格上涨需要紧急行动,我们不能等了。”</p>\n<p>同在周三,英国能源企业和业界组织也对今年冬季的能源危机发出警告。媒体称,英国的议员感到恐慌,可能为保护国内家庭而寻求设定电费上限。</p>\n<p>10、联合国安理会投票通过为阿富汗提供人道援助的决议</p>\n<p>当地时间22日,联合国安理会一致通过决议,向处于经济崩溃边缘的阿富汗提供人道主义援助。中国常驻联合国代表张军表示,中方支持联合国发挥更大协调作用,呼吁所有国际伙伴加大对阿援助力度,并解除对阿制裁。</p>\n<p><b>公司新闻</b></p>\n<p>1、<a href=\"https://laohu8.com/NW/2193115827\" target=\"_blank\">特斯拉股价一度大涨逾8% 市值重返1万亿美元上方</a></p>\n<p>特斯拉股价周三一度大涨逾8%,助其市值重返1万亿美元上方,此前该公司CEO埃隆•马斯克在接受采访时透露,他已完成了出售10%所持特斯拉股票的目标。</p>\n<p>Wedbush分析师Dan Ives评价道,在经历了几周的黑暗后,特斯拉终于迎来了好消息,马斯克的这一声明消除了对特斯拉股价的威胁,抛售压力和负面看法问题已经解决,投资者重新关注华尔街的基本面驱动因素。</p>\n<p>2、<a href=\"https://laohu8.com/NW/2193116621\" target=\"_blank\">苹果汽车早产!供应链称Apple Car将于明年9月发布</a></p>\n<p>12月2日消息,有媒体报道称,苹果首款电动车「Apple Car」有望将提前问世。此前,外界原本预期苹果至少要到 2023 年才会推出 Apple Car。不过,国内供应链大厂董座直言,苹果正准备在明年 9 月推出 Apple Car。某电动车供应链大厂高层透露,随着订单出货、组装完成,Apple Car 首款原型车,已有数十辆秘密在美国加州上路测试中,预计出货量与商机将会在明年初显,2022 年全面爆发。</p>\n<p>3、<a href=\"https://laohu8.com/NW/2193172113\" target=\"_blank\">辉瑞新冠口服药获美国FDA紧急授权</a></p>\n<p>当地时间22日,辉瑞公司生产的抗新冠病毒口服药PAXLOVID获得了美国食品药品监督管理局的紧急使用授权,可以用于治疗出现轻度至中度症状的新冠肺炎患者。</p>\n<p>4、<a href=\"https://laohu8.com/NW/2193118492\" target=\"_blank\">美国联邦贸易委员会对亚马逊云计算业务展开新的反垄断调查</a></p>\n<p>知情人士透露,美国联邦贸易委员会(FTC)正在推进对亚马逊云计算业务的反垄断调查。</p>\n<p>FTC主席Lina Khan一直是亚马逊的批评者,正在推进前任主席几年前启动的一项调查。</p>\n<p>亚马逊160亿美元的云计算业务也是该公司最大的利润源。调查这项业务之际,Khan早已把目标瞄准了美国一些最大的科技公司。Khan曾是哥伦比亚大学法学院教授,在反垄断界大名鼎鼎,一直警告亚马逊之类公司对数字经济时代的竞争构成威胁。</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>昨夜今晨:美股指两连涨!特斯拉大涨超7%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n昨夜今晨:美股指两连涨!特斯拉大涨超7%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2021-12-23 07:56</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<blockquote>\n 摘要:①纳指涨1.18%,新能源汽车股表现强势,特斯拉大涨7.5%;\n</blockquote>\n<blockquote>\n ②美国三季度实际GDP年化季环比终值 2.3%,较二季度增速大幅放缓;\n</blockquote>\n<blockquote>\n ③供应链称苹果首款电动车Apple Car将于明年9月发布。\n</blockquote>\n<p></p>\n<p><b>海外市场</b></p>\n<p>1、美股指两连涨!纳指涨超1% 特斯拉大涨7.5%</p>\n<p>美股三大指数集体收涨,主要股指连续第二个交易日反弹。美国总统拜登督促民众接种加强针,并表示不会恢复疫情爆发初期实施的严格封锁措施。美国第三季度GDP增长2.3%,好于市场预期。截至收盘,纳斯达克指数涨1.18%,标普500指数涨1.02%,道琼斯指数涨0.74%。</p>\n<p>新能源汽车股表现强势,SonoGroup涨近14%;特斯拉收涨7.5%,创11月1日以来最大单日涨幅,市值当日暴增706.21亿美元(约合人民币4498亿元)。</p>\n<p>小鹏汽车涨超4%,理想汽车涨1.4%。大型科技股集体走高,苹果涨1.53%,亚马逊涨0.36%,Meta跌1.12%,谷歌涨2.05%,微软涨1.81%,奈飞涨1.54%。</p>\n<p>2、热门中概股多数收跌 阿里跌超4%</p>\n<p>阿里巴巴跌超4%,此前阿里云被暂停作为工信部网络安全威胁信息共享平台合作单位</p>\n<p>其他中概股方面,雾芯科技涨超2%,京东微涨;贝壳收平,百度跌近1%,金山云、新东方跌超1%,滴滴跌超6%,好未来跌超3%,搜狐跌超2%。</p>\n<p>3、欧股主要指数上涨,法国CAC40指数涨超1%</p>\n<p>德国DAX30指数收涨0.91%,英国富时100指数涨0.60%,法国CAC40指数涨1.24%,欧洲斯托克50指数涨1.00%。</p>\n<p>4、原油库存降幅超预期 美油收高2.3%</p>\n<p>因美国能源信息署(EIA)报告称美国原油库存降幅超出预期,令油价得到支撑。最终,纽约商品交易所2月交割的西德克萨斯中质原油(WTI)期货价格上涨1.64美元,涨幅为2.3%,收于每桶72.76美元。</p>\n<p>5、黄金期货收高0.8% 站上1800美元关口</p>\n<p>最近黄金期货多次测试1800美元关口,但未能长时间维持在其上方。但在周三,美元走软和美国国债收益率低迷,帮助金价站上这一关口。</p>\n<p>最终,纽约商品交易所2月交割的黄金期货价格上涨13.50美元,涨幅为0.8%,收于每盎司1802.20美元。</p>\n<p>6、土耳其股市连续4个交易日收跌 22日触发一次熔断</p>\n<p>当地时间22日,土耳其伊斯坦布尔100指数开盘报1.832.14点,较前一日收盘下跌3.14%。当地时间14时39分,股指下跌超5%,触发熔断。随后股指持续震荡,当天收盘时跌幅为4.64%。这是土耳其股市连续第四个交易日收跌。</p>\n<p>分析人士指出,土耳其财政和货币政策的不可预测性,让投资者信心受到影响,在这种情况下,很多投资者可能会选择撤离观望。</p>\n<p>由于总统埃尔多安推动货币宽松政策,土耳其央行9月以来已经累计下调基准利率500个基点,而每次下调都使得里拉进一步贬值,和年初相比,里拉跌幅曾一度超过55%。</p>\n<p><b>国际宏观</b></p>\n<p>1、拜登声称假日季供应链危机已避免 呼吁通过重建更美好未来法案</p>\n<p>美国总统乔·拜登表示,他的政府与工会和企业一起成功避免了假日季节的供应链危机。</p>\n<p>“今年秋天的时候,我们听到很多关于供应链问题的可怕警告,声称假日前后会出现危机,”拜登在白宫说。 “所以我们采取了行动。我们召集了商界和劳工界的领袖来解决问题。这场被预测很可能发生的危机并未出现。”</p>\n<p>2、美国三季度实际GDP年化季环比终值 2.3%,较二季度增速大幅放缓</p>\n<p>美国三季度实际GDP年化季环比终值 2.3%,预期 2.1%,前值 2.1%,是自2020年第二季度以来的最低增速。三季度增长放缓主要是由于全球供应链紧张导致供应短缺,以及政府向企业、家庭、和地方政府提供的疫情支持资金减少。</p>\n<p>3、美国三季度核心PCE物价指数创近30年新高 符合预期</p>\n<p>12月22日周三,据美国商务部统计,美国第三季度核心PCE物价指数年化季环比终值上涨4.6%,略高于4.5%的前值和预期;同比终值上升3.6%,与预期持平,仍是近30年最高水平。</p>\n<p>4、今年美国IPO发行量创下历史纪录 但回报率差强人意</p>\n<p>根据彭博汇编的数据,今年481宗美国IPO中有一半以上的交易价格低于发行价。这些交易,不包括更多的特殊目的收购公司,总共创下了约1670亿美元的记录,轻松超越2020年。</p>\n<p>尽管发行金额创下历史新高,但由于波动性和表现不佳,对IPO的热情在年底有所减弱。交易商表示,尽管2022年第一季看起来将十分忙录,但预计未来一年会较为波动。</p>\n<p>5、美国11月二手房销量连续第三个月增长</p>\n<p>美国全国地产经纪商协会周三公布的数据显示,11月二手房销量环比增长1.9%,折合年率达646万套,创下1月以来最大增幅。彭博调查预估中值为6.53万套。</p>\n<p>该数据表明住房需求正在加速上升,尤其是在高端市场,因为贷款成本仍远低于新冠疫情前的水平。即便如此,高房价也可能使一些潜在买家望而却步,尤其是收入水平较低、受通胀打击更大的消费者。</p>\n<p>6、美国12月消费者信心指数上升 克服了Omicron带来的恐慌</p>\n<p>世界大型企业研究会周三的报告显示,消费者信心指数升至115.8,11月数据被向上修正为111.9。接受彭博调查的经济学家预期为111。</p>\n<p>数据显示,尽管随着omicron的传播,美国一些地区实施了新的防疫限制措施,但消费者心态仍乐观。美联储主席鲍威尔和多位经济学家表示,随着美国人对新冠病毒及其变异株的适应性增强,每一波疫情带来的经济影响会变得较小。</p>\n<p>7、世卫组织正在确定第二代新冠疫苗</p>\n<p>世卫组织总干事谭德塞在22日的新闻发布会上透露,世卫组织正在通过疫苗“团结试验”确定第二代新冠疫苗。</p>\n<p>谭德塞表示,相关研究团队于9月下旬开始招募志愿者,到目前为止,已有超过11500人参加了试验。截至目前,该试验包括两种疫苗,另外三种疫苗不久将被纳入,而且还可能纳入更多的疫苗。世卫组织邀请所有国家和研究中心参与这项试验。</p>\n<p>8、美国政府宣布将学生贷款偿还期限延至明年5月1日</p>\n<p>当地时间22日,美国白宫新闻秘书珍·普萨基在简报会上证实,拜登已经宣布将学生贷款的偿还期限延长90天,到明年的5月1日。普萨基说,部分学生贷款的借款人受到新冠肺炎疫情的影响,需要时间偿还。</p>\n<p>9、欧洲能源告急!天然气狂飙新高 英国企业称正处国家危机 意大利总理高呼需紧急行动</p>\n<p>天然气暴涨也让欧洲国家坐不住了。本周三,意大利总理德拉吉在年末新闻发布会上表示,遏制能源短缺亟需采取紧急政策行动:“能源价格上涨需要紧急行动,我们不能等了。”</p>\n<p>同在周三,英国能源企业和业界组织也对今年冬季的能源危机发出警告。媒体称,英国的议员感到恐慌,可能为保护国内家庭而寻求设定电费上限。</p>\n<p>10、联合国安理会投票通过为阿富汗提供人道援助的决议</p>\n<p>当地时间22日,联合国安理会一致通过决议,向处于经济崩溃边缘的阿富汗提供人道主义援助。中国常驻联合国代表张军表示,中方支持联合国发挥更大协调作用,呼吁所有国际伙伴加大对阿援助力度,并解除对阿制裁。</p>\n<p><b>公司新闻</b></p>\n<p>1、<a href=\"https://laohu8.com/NW/2193115827\" target=\"_blank\">特斯拉股价一度大涨逾8% 市值重返1万亿美元上方</a></p>\n<p>特斯拉股价周三一度大涨逾8%,助其市值重返1万亿美元上方,此前该公司CEO埃隆•马斯克在接受采访时透露,他已完成了出售10%所持特斯拉股票的目标。</p>\n<p>Wedbush分析师Dan Ives评价道,在经历了几周的黑暗后,特斯拉终于迎来了好消息,马斯克的这一声明消除了对特斯拉股价的威胁,抛售压力和负面看法问题已经解决,投资者重新关注华尔街的基本面驱动因素。</p>\n<p>2、<a href=\"https://laohu8.com/NW/2193116621\" target=\"_blank\">苹果汽车早产!供应链称Apple Car将于明年9月发布</a></p>\n<p>12月2日消息,有媒体报道称,苹果首款电动车「Apple Car」有望将提前问世。此前,外界原本预期苹果至少要到 2023 年才会推出 Apple Car。不过,国内供应链大厂董座直言,苹果正准备在明年 9 月推出 Apple Car。某电动车供应链大厂高层透露,随着订单出货、组装完成,Apple Car 首款原型车,已有数十辆秘密在美国加州上路测试中,预计出货量与商机将会在明年初显,2022 年全面爆发。</p>\n<p>3、<a href=\"https://laohu8.com/NW/2193172113\" target=\"_blank\">辉瑞新冠口服药获美国FDA紧急授权</a></p>\n<p>当地时间22日,辉瑞公司生产的抗新冠病毒口服药PAXLOVID获得了美国食品药品监督管理局的紧急使用授权,可以用于治疗出现轻度至中度症状的新冠肺炎患者。</p>\n<p>4、<a href=\"https://laohu8.com/NW/2193118492\" target=\"_blank\">美国联邦贸易委员会对亚马逊云计算业务展开新的反垄断调查</a></p>\n<p>知情人士透露,美国联邦贸易委员会(FTC)正在推进对亚马逊云计算业务的反垄断调查。</p>\n<p>FTC主席Lina Khan一直是亚马逊的批评者,正在推进前任主席几年前启动的一项调查。</p>\n<p>亚马逊160亿美元的云计算业务也是该公司最大的利润源。调查这项业务之际,Khan早已把目标瞄准了美国一些最大的科技公司。Khan曾是哥伦比亚大学法学院教授,在反垄断界大名鼎鼎,一直警告亚马逊之类公司对数字经济时代的竞争构成威胁。</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/b23574aac95526c9e5c62ebc8dd25130","relate_stocks":{".IXIC":"NASDAQ Composite",".DJI":"道琼斯",".SPX":"S&P 500 Index"},"is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1183786099","content_text":"摘要:①纳指涨1.18%,新能源汽车股表现强势,特斯拉大涨7.5%;\n\n\n ②美国三季度实际GDP年化季环比终值 2.3%,较二季度增速大幅放缓;\n\n\n ③供应链称苹果首款电动车Apple Car将于明年9月发布。\n\n\n海外市场\n1、美股指两连涨!纳指涨超1% 特斯拉大涨7.5%\n美股三大指数集体收涨,主要股指连续第二个交易日反弹。美国总统拜登督促民众接种加强针,并表示不会恢复疫情爆发初期实施的严格封锁措施。美国第三季度GDP增长2.3%,好于市场预期。截至收盘,纳斯达克指数涨1.18%,标普500指数涨1.02%,道琼斯指数涨0.74%。\n新能源汽车股表现强势,SonoGroup涨近14%;特斯拉收涨7.5%,创11月1日以来最大单日涨幅,市值当日暴增706.21亿美元(约合人民币4498亿元)。\n小鹏汽车涨超4%,理想汽车涨1.4%。大型科技股集体走高,苹果涨1.53%,亚马逊涨0.36%,Meta跌1.12%,谷歌涨2.05%,微软涨1.81%,奈飞涨1.54%。\n2、热门中概股多数收跌 阿里跌超4%\n阿里巴巴跌超4%,此前阿里云被暂停作为工信部网络安全威胁信息共享平台合作单位\n其他中概股方面,雾芯科技涨超2%,京东微涨;贝壳收平,百度跌近1%,金山云、新东方跌超1%,滴滴跌超6%,好未来跌超3%,搜狐跌超2%。\n3、欧股主要指数上涨,法国CAC40指数涨超1%\n德国DAX30指数收涨0.91%,英国富时100指数涨0.60%,法国CAC40指数涨1.24%,欧洲斯托克50指数涨1.00%。\n4、原油库存降幅超预期 美油收高2.3%\n因美国能源信息署(EIA)报告称美国原油库存降幅超出预期,令油价得到支撑。最终,纽约商品交易所2月交割的西德克萨斯中质原油(WTI)期货价格上涨1.64美元,涨幅为2.3%,收于每桶72.76美元。\n5、黄金期货收高0.8% 站上1800美元关口\n最近黄金期货多次测试1800美元关口,但未能长时间维持在其上方。但在周三,美元走软和美国国债收益率低迷,帮助金价站上这一关口。\n最终,纽约商品交易所2月交割的黄金期货价格上涨13.50美元,涨幅为0.8%,收于每盎司1802.20美元。\n6、土耳其股市连续4个交易日收跌 22日触发一次熔断\n当地时间22日,土耳其伊斯坦布尔100指数开盘报1.832.14点,较前一日收盘下跌3.14%。当地时间14时39分,股指下跌超5%,触发熔断。随后股指持续震荡,当天收盘时跌幅为4.64%。这是土耳其股市连续第四个交易日收跌。\n分析人士指出,土耳其财政和货币政策的不可预测性,让投资者信心受到影响,在这种情况下,很多投资者可能会选择撤离观望。\n由于总统埃尔多安推动货币宽松政策,土耳其央行9月以来已经累计下调基准利率500个基点,而每次下调都使得里拉进一步贬值,和年初相比,里拉跌幅曾一度超过55%。\n国际宏观\n1、拜登声称假日季供应链危机已避免 呼吁通过重建更美好未来法案\n美国总统乔·拜登表示,他的政府与工会和企业一起成功避免了假日季节的供应链危机。\n“今年秋天的时候,我们听到很多关于供应链问题的可怕警告,声称假日前后会出现危机,”拜登在白宫说。 “所以我们采取了行动。我们召集了商界和劳工界的领袖来解决问题。这场被预测很可能发生的危机并未出现。”\n2、美国三季度实际GDP年化季环比终值 2.3%,较二季度增速大幅放缓\n美国三季度实际GDP年化季环比终值 2.3%,预期 2.1%,前值 2.1%,是自2020年第二季度以来的最低增速。三季度增长放缓主要是由于全球供应链紧张导致供应短缺,以及政府向企业、家庭、和地方政府提供的疫情支持资金减少。\n3、美国三季度核心PCE物价指数创近30年新高 符合预期\n12月22日周三,据美国商务部统计,美国第三季度核心PCE物价指数年化季环比终值上涨4.6%,略高于4.5%的前值和预期;同比终值上升3.6%,与预期持平,仍是近30年最高水平。\n4、今年美国IPO发行量创下历史纪录 但回报率差强人意\n根据彭博汇编的数据,今年481宗美国IPO中有一半以上的交易价格低于发行价。这些交易,不包括更多的特殊目的收购公司,总共创下了约1670亿美元的记录,轻松超越2020年。\n尽管发行金额创下历史新高,但由于波动性和表现不佳,对IPO的热情在年底有所减弱。交易商表示,尽管2022年第一季看起来将十分忙录,但预计未来一年会较为波动。\n5、美国11月二手房销量连续第三个月增长\n美国全国地产经纪商协会周三公布的数据显示,11月二手房销量环比增长1.9%,折合年率达646万套,创下1月以来最大增幅。彭博调查预估中值为6.53万套。\n该数据表明住房需求正在加速上升,尤其是在高端市场,因为贷款成本仍远低于新冠疫情前的水平。即便如此,高房价也可能使一些潜在买家望而却步,尤其是收入水平较低、受通胀打击更大的消费者。\n6、美国12月消费者信心指数上升 克服了Omicron带来的恐慌\n世界大型企业研究会周三的报告显示,消费者信心指数升至115.8,11月数据被向上修正为111.9。接受彭博调查的经济学家预期为111。\n数据显示,尽管随着omicron的传播,美国一些地区实施了新的防疫限制措施,但消费者心态仍乐观。美联储主席鲍威尔和多位经济学家表示,随着美国人对新冠病毒及其变异株的适应性增强,每一波疫情带来的经济影响会变得较小。\n7、世卫组织正在确定第二代新冠疫苗\n世卫组织总干事谭德塞在22日的新闻发布会上透露,世卫组织正在通过疫苗“团结试验”确定第二代新冠疫苗。\n谭德塞表示,相关研究团队于9月下旬开始招募志愿者,到目前为止,已有超过11500人参加了试验。截至目前,该试验包括两种疫苗,另外三种疫苗不久将被纳入,而且还可能纳入更多的疫苗。世卫组织邀请所有国家和研究中心参与这项试验。\n8、美国政府宣布将学生贷款偿还期限延至明年5月1日\n当地时间22日,美国白宫新闻秘书珍·普萨基在简报会上证实,拜登已经宣布将学生贷款的偿还期限延长90天,到明年的5月1日。普萨基说,部分学生贷款的借款人受到新冠肺炎疫情的影响,需要时间偿还。\n9、欧洲能源告急!天然气狂飙新高 英国企业称正处国家危机 意大利总理高呼需紧急行动\n天然气暴涨也让欧洲国家坐不住了。本周三,意大利总理德拉吉在年末新闻发布会上表示,遏制能源短缺亟需采取紧急政策行动:“能源价格上涨需要紧急行动,我们不能等了。”\n同在周三,英国能源企业和业界组织也对今年冬季的能源危机发出警告。媒体称,英国的议员感到恐慌,可能为保护国内家庭而寻求设定电费上限。\n10、联合国安理会投票通过为阿富汗提供人道援助的决议\n当地时间22日,联合国安理会一致通过决议,向处于经济崩溃边缘的阿富汗提供人道主义援助。中国常驻联合国代表张军表示,中方支持联合国发挥更大协调作用,呼吁所有国际伙伴加大对阿援助力度,并解除对阿制裁。\n公司新闻\n1、特斯拉股价一度大涨逾8% 市值重返1万亿美元上方\n特斯拉股价周三一度大涨逾8%,助其市值重返1万亿美元上方,此前该公司CEO埃隆•马斯克在接受采访时透露,他已完成了出售10%所持特斯拉股票的目标。\nWedbush分析师Dan Ives评价道,在经历了几周的黑暗后,特斯拉终于迎来了好消息,马斯克的这一声明消除了对特斯拉股价的威胁,抛售压力和负面看法问题已经解决,投资者重新关注华尔街的基本面驱动因素。\n2、苹果汽车早产!供应链称Apple Car将于明年9月发布\n12月2日消息,有媒体报道称,苹果首款电动车「Apple Car」有望将提前问世。此前,外界原本预期苹果至少要到 2023 年才会推出 Apple Car。不过,国内供应链大厂董座直言,苹果正准备在明年 9 月推出 Apple Car。某电动车供应链大厂高层透露,随着订单出货、组装完成,Apple Car 首款原型车,已有数十辆秘密在美国加州上路测试中,预计出货量与商机将会在明年初显,2022 年全面爆发。\n3、辉瑞新冠口服药获美国FDA紧急授权\n当地时间22日,辉瑞公司生产的抗新冠病毒口服药PAXLOVID获得了美国食品药品监督管理局的紧急使用授权,可以用于治疗出现轻度至中度症状的新冠肺炎患者。\n4、美国联邦贸易委员会对亚马逊云计算业务展开新的反垄断调查\n知情人士透露,美国联邦贸易委员会(FTC)正在推进对亚马逊云计算业务的反垄断调查。\nFTC主席Lina Khan一直是亚马逊的批评者,正在推进前任主席几年前启动的一项调查。\n亚马逊160亿美元的云计算业务也是该公司最大的利润源。调查这项业务之际,Khan早已把目标瞄准了美国一些最大的科技公司。Khan曾是哥伦比亚大学法学院教授,在反垄断界大名鼎鼎,一直警告亚马逊之类公司对数字经济时代的竞争构成威胁。","news_type":1},"isVote":1,"tweetType":1,"viewCount":966,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605267036,"gmtCreate":1639182635685,"gmtModify":1639182635685,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087463284623270","idStr":"4087463284623270"},"themes":[],"htmlText":"[What] ","listText":"[What] ","text":"[What]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/605267036","repostId":"1148141788","repostType":4,"repost":{"id":"1148141788","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639147224,"share":"https://www.laohu8.com/m/news/1148141788?lang=&edition=full","pubTime":"2021-12-10 22:40","market":"us","language":"en","title":"Vaccine stocks dropped in morning trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1148141788","media":"Tiger Newspress","summary":"Vaccine stocks dropped in morning trading.Moderna,BioNTech and Novavax fell between 2% and 11%.","content":"<p>Vaccine stocks dropped in morning trading.Moderna,BioNTech and Novavax fell between 2% and 11%.</p>\n<p><img src=\"https://static.tigerbbs.com/d3f84cfc9f83b59cf14210d41d97111a\" tg-width=\"415\" tg-height=\"302\" width=\"100%\" height=\"auto\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vaccine stocks dropped in morning trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVaccine stocks dropped in morning trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-10 22:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Vaccine stocks dropped in morning trading.Moderna,BioNTech and Novavax fell between 2% and 11%.</p>\n<p><img src=\"https://static.tigerbbs.com/d3f84cfc9f83b59cf14210d41d97111a\" tg-width=\"415\" tg-height=\"302\" width=\"100%\" height=\"auto\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药","MRNA":"Moderna, Inc.","BNTX":"BioNTech SE"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1148141788","content_text":"Vaccine stocks dropped in morning trading.Moderna,BioNTech and Novavax fell between 2% and 11%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1306,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":606427974,"gmtCreate":1638922262420,"gmtModify":1638922262420,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087463284623270","idStr":"4087463284623270"},"themes":[],"htmlText":"[Grin] ","listText":"[Grin] ","text":"[Grin]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/606427974","repostId":"1159685639","repostType":4,"repost":{"id":"1159685639","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638888367,"share":"https://www.laohu8.com/m/news/1159685639?lang=&edition=full","pubTime":"2021-12-07 22:46","market":"us","language":"en","title":"Apple shares rose more than 3% to a new high","url":"https://stock-news.laohu8.com/highlight/detail?id=1159685639","media":"Tiger Newspress","summary":"Apple shares rose more than 3% to a new high after the company got another street-high target on vir","content":"<p>Apple shares rose more than 3% to a new high after the company got another street-high target on virtual reality boost.</p>\n<p><img src=\"https://static.tigerbbs.com/eb9792aa89d24847aee38f67d56067eb\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p>\n<p>Apple Inc. got its second Street-high price target as Morgan Stanley sees it benefiting from new product categories in virtual reality and autonomous vehicles.</p>\n<p>Analyst Katy Huberty, who rates Apple overweight, raised her price target to $200 from $164, matching Wedbush as the highest among targets tracked by Bloomberg. </p>\n<p>While investors have struggled to value the iPhone maker’s new products given the company’s secrecy, Huberty expects augmented and virtual reality, as well as autonomous vehicles, to eventually be priced in, and says Apple should also benefit from a “flight to quality” in technology stocks.</p>\n<p>“Despite a consistent and material revenue contribution from new products and services over time, Apple shares don’t seem to bake in the impact from upcoming new product launches,” Huberty wrote in a note. “We believe this will change as Apple approaches the launch of an AR/VR product over the next year.”</p>\n<p><img src=\"https://static.tigerbbs.com/7d1d69bd985c3b74963515674f2da918\" tg-width=\"1200\" tg-height=\"675\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>Apple’s shares have surged 25% this year and ended Monday’s session at a fresh record. Investors consider the tech giant a safe bet in an increasingly volatile market, as the highest-valued names in the sector get hit by hawkish signals from the Federal Reserve.</p>\n<p>Huberty also increased her estimates for Apple’s December quarter, citing improving iPhone supply as manufacturing disruptions ease.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple shares rose more than 3% to a new high</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple shares rose more than 3% to a new high\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-07 22:46</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Apple shares rose more than 3% to a new high after the company got another street-high target on virtual reality boost.</p>\n<p><img src=\"https://static.tigerbbs.com/eb9792aa89d24847aee38f67d56067eb\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p>\n<p>Apple Inc. got its second Street-high price target as Morgan Stanley sees it benefiting from new product categories in virtual reality and autonomous vehicles.</p>\n<p>Analyst Katy Huberty, who rates Apple overweight, raised her price target to $200 from $164, matching Wedbush as the highest among targets tracked by Bloomberg. </p>\n<p>While investors have struggled to value the iPhone maker’s new products given the company’s secrecy, Huberty expects augmented and virtual reality, as well as autonomous vehicles, to eventually be priced in, and says Apple should also benefit from a “flight to quality” in technology stocks.</p>\n<p>“Despite a consistent and material revenue contribution from new products and services over time, Apple shares don’t seem to bake in the impact from upcoming new product launches,” Huberty wrote in a note. “We believe this will change as Apple approaches the launch of an AR/VR product over the next year.”</p>\n<p><img src=\"https://static.tigerbbs.com/7d1d69bd985c3b74963515674f2da918\" tg-width=\"1200\" tg-height=\"675\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>Apple’s shares have surged 25% this year and ended Monday’s session at a fresh record. Investors consider the tech giant a safe bet in an increasingly volatile market, as the highest-valued names in the sector get hit by hawkish signals from the Federal Reserve.</p>\n<p>Huberty also increased her estimates for Apple’s December quarter, citing improving iPhone supply as manufacturing disruptions ease.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1159685639","content_text":"Apple shares rose more than 3% to a new high after the company got another street-high target on virtual reality boost.\n\nApple Inc. got its second Street-high price target as Morgan Stanley sees it benefiting from new product categories in virtual reality and autonomous vehicles.\nAnalyst Katy Huberty, who rates Apple overweight, raised her price target to $200 from $164, matching Wedbush as the highest among targets tracked by Bloomberg. \nWhile investors have struggled to value the iPhone maker’s new products given the company’s secrecy, Huberty expects augmented and virtual reality, as well as autonomous vehicles, to eventually be priced in, and says Apple should also benefit from a “flight to quality” in technology stocks.\n“Despite a consistent and material revenue contribution from new products and services over time, Apple shares don’t seem to bake in the impact from upcoming new product launches,” Huberty wrote in a note. “We believe this will change as Apple approaches the launch of an AR/VR product over the next year.”\n\nApple’s shares have surged 25% this year and ended Monday’s session at a fresh record. Investors consider the tech giant a safe bet in an increasingly volatile market, as the highest-valued names in the sector get hit by hawkish signals from the Federal Reserve.\nHuberty also increased her estimates for Apple’s December quarter, citing improving iPhone supply as manufacturing disruptions ease.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1605,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":608147410,"gmtCreate":1638672022759,"gmtModify":1638672022759,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087463284623270","idStr":"4087463284623270"},"themes":[],"htmlText":"[Sad] ","listText":"[Sad] ","text":"[Sad]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/608147410","repostId":"1115309845","repostType":4,"repost":{"id":"1115309845","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638541913,"share":"https://www.laohu8.com/m/news/1115309845?lang=&edition=full","pubTime":"2021-12-03 22:31","market":"us","language":"en","title":"Stocks gain on Friday to close out volatile week triggered by omicron fears","url":"https://stock-news.laohu8.com/highlight/detail?id=1115309845","media":"Tiger Newspress","summary":"Stocks rose in early trading Friday, looking past a disappointing November jobs report, as the marke","content":"<p>Stocks rose in early trading Friday, looking past a disappointing November jobs report, as the market nears the end of a roller-coaster week driven by Covid omicron variant developments.</p>\n<p>The Dow Jones Industrial Average rose about 100 points. The S&P 500 rose 0.43% and the technology-focused Nasdaq Composite rose 0.3%.</p>\n<p><img src=\"https://static.tigerbbs.com/f06b0aca63dcdc023083815943f6832a\" tg-width=\"1057\" tg-height=\"455\" referrerpolicy=\"no-referrer\"></p>\n<p>RLX Technology stock tumbled 6% as its Q3 <b>Net revenues</b> decreased by 34%.</p>\n<p>Marvell Technology shares soared 20% after delivering a better-than-expected earnings report and outlook.</p>\n<p>DocuSign shares tumbled 35% on Weak Sales Forecast.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stocks gain on Friday to close out volatile week triggered by omicron fears</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStocks gain on Friday to close out volatile week triggered by omicron fears\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-03 22:31</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Stocks rose in early trading Friday, looking past a disappointing November jobs report, as the market nears the end of a roller-coaster week driven by Covid omicron variant developments.</p>\n<p>The Dow Jones Industrial Average rose about 100 points. The S&P 500 rose 0.43% and the technology-focused Nasdaq Composite rose 0.3%.</p>\n<p><img src=\"https://static.tigerbbs.com/f06b0aca63dcdc023083815943f6832a\" tg-width=\"1057\" tg-height=\"455\" referrerpolicy=\"no-referrer\"></p>\n<p>RLX Technology stock tumbled 6% as its Q3 <b>Net revenues</b> decreased by 34%.</p>\n<p>Marvell Technology shares soared 20% after delivering a better-than-expected earnings report and outlook.</p>\n<p>DocuSign shares tumbled 35% on Weak Sales Forecast.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".DJI":"道琼斯",".IXIC":"NASDAQ Composite"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1115309845","content_text":"Stocks rose in early trading Friday, looking past a disappointing November jobs report, as the market nears the end of a roller-coaster week driven by Covid omicron variant developments.\nThe Dow Jones Industrial Average rose about 100 points. The S&P 500 rose 0.43% and the technology-focused Nasdaq Composite rose 0.3%.\n\nRLX Technology stock tumbled 6% as its Q3 Net revenues decreased by 34%.\nMarvell Technology shares soared 20% after delivering a better-than-expected earnings report and outlook.\nDocuSign shares tumbled 35% on Weak Sales Forecast.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1355,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":154245077,"gmtCreate":1625531763299,"gmtModify":1633939969682,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087463284623270","idStr":"4087463284623270"},"themes":[],"htmlText":"okay ","listText":"okay ","text":"okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/154245077","repostId":"1110936297","repostType":2,"repost":{"id":"1110936297","kind":"news","pubTimestamp":1625036047,"share":"https://www.laohu8.com/m/news/1110936297?lang=&edition=full","pubTime":"2021-06-30 14:54","market":"us","language":"en","title":"Apple: Act Quickly Before The Run To $172","url":"https://stock-news.laohu8.com/highlight/detail?id=1110936297","media":"seekingalpha","summary":"Apple faces many external threats from regulators in the developed world.But I see these as largely priced in, although they remain a threat longer term.Apple is on the cusp of what should be a pre-earnings run and an imminent breakout of a bullish consolidation pattern.I have made it no secret that I’m a big fan of Apple. In fact, I wrote a very bullish piece about six weeks ago, detailing how I thought Apple was in the process of consolidating before a big breakout. In this article, I want to ","content":"<p><b>Summary</b></p>\n<ul>\n <li>Apple faces many external threats from regulators in the developed world.</li>\n <li>But I see these as largely priced in, although they remain a threat longer term.</li>\n <li>Apple is on the cusp of what should be a pre-earnings run and an imminent breakout of a bullish consolidation pattern.</li>\n</ul>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/219c4f41554f7e91be4c02cd87e3f8d6\" tg-width=\"1536\" tg-height=\"1024\"><span>fMing Yeung/Getty Images News</span></p>\n<p>I have made it no secret that I’m a big fan of <b>Apple</b>(AAPL). In fact, I wrote a very bullish piece about six weeks ago, detailing how I thought Apple was in the process of consolidating before a big breakout. In this article, I want to update readers on the progress of that, as well as addressing some concerns that could be potentially bearish. But the spoiler alert is that I’m still very much in the camp of Apple setting up a breakout, and I think the company’s typical pre-earnings move is likely the catalyst to see that happen.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/37078c4ff01404a43176bb2e2555834d\" tg-width=\"640\" tg-height=\"615\"><span>Source: StockCharts</span></p>\n<p>To start, I’ve annotated the same ascending triangle formation I noted six weeks ago, because it is still very much in play. The stock is very near the top of the triangle today, so what happens when/if it gets to $136/$137 will determine if the breakout is imminent or if we need at least one more test of the rising trend line that forms the bottom of the triangle. Whether that occurs or not doesn’t change my outlook; only the timing of it.</p>\n<p>Ascending triangles measure upside targets on breakouts equal to the top and bottom of the widest part of the triangle. In this case, the top of the triangle is $137 and the bottom of the triangle, which was set in September of last year, was $102. That means that this triangle pattern has a measured price target – after the breakout – of $35 higher ($137 minus $102), and with the breakout point being $137 or so, that implies we canexpect Apple to hit $172, give or take. Now, that won’t happen immediately, of course, but that’s the kind of opportunity at hand here.</p>\n<p>What do you need to look for on a breakout? First, price action needs to decisively clear the breakout level of $137 and close above it. In addition, you want to see rising volume on the breakout – I’ve annotated declining volume in the triangle period, which is normal behavior – and you want to see rising momentum, we’ve got rising momentum today. So I’d expect a breakout to continue that, but these are the things you want to see on a breakout to ensure it has staying power.</p>\n<p>Finally, you’ll notice that I’ve added blue circles on the chart, and those represent the start of the ~4-week period prior to an earnings release. Apple has been<i>very</i>reliable in the past couple of years in terms of rallying into an earnings report, and I have no reason to think that will change. The gains are fairly large in most cases, with about half of them being in the double-digits, so this is a real catalyst for higher prices.</p>\n<p>The important thing to note is that we are about four weeks from the third quarter report, which typically takes place at the end of July. We are also at the top of the ascending triangle, which means that even a small pre-earnings run will likely result in a breakout, and that’s why I think the breakout is very near.</p>\n<p>To be clear, I’m reiterating my prior thesis that an ascending triangle breakout is coming; I just think we have a very clear catalyst now to make it sooner than later. I see the stock rallying into the earnings report, and if history is a guide, Apple will destroy expectations once again. In short, all is going to plan.</p>\n<p>The risk is that if Apple does break out of the triangle and earnings aren’t very good, the pattern could fail. That would negate my $172 price target, and we’d have to reassess. For now, the odds of that look low, and I’m still full steam ahead on the breakout coming pre-earnings.</p>\n<p><b>Why does Apple rally pre-earnings?</b></p>\n<p>To put it succinctly, Apple rallies pre-earnings because no matter how much analysts raise their targets going into the reports, Apple finds a way to beat them.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/6233212bc10ea38f20e75d2ed0ab603e\" tg-width=\"640\" tg-height=\"284\"><span>Source:Seeking Alpha</span></p>\n<p>This is three years’ worth of data showing how Apple beats expectations, and by enormous margins in some cases. Apple is one of the largest and most-followed companies that has ever existed. So if any company should have an analyst community that knows how it will perform each quarter, it would be this one. However, its dominance in hardware and services revenue has proven too much for analysts over time to keep up with.</p>\n<p>Keep in mind a risk here is that if Apple does finally miss expectations, I have to imagine the stock will react extremely poorly. Thus, there is certainly risk in owning Apple through the earnings report, as with any other stock. But the company’s history of smashing expectations – particularly in the past year – means the odds of this are fairly low. Still, something to keep in mind from a risk perspective.</p>\n<p>In terms of a catalyst for rallying into the July report, Apple continues to see analysts scramble to keep up with its rising fortunes.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ebf56ca48e2364fd7314f9140bc3ab5c\" tg-width=\"640\" tg-height=\"286\"><span>Source:Seeking Alpha</span></p>\n<p>The sharp upward revisions that began last summer continue unabated, and Apple’s earnings trajectory remains very much intact. I detailed this in my last piece so I’m simply saying that nothing has changed on this front, and that’s a very good thing.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/d2bd9aaadd1cc3a29d7b8e787296ab4b\" tg-width=\"454\" tg-height=\"110\"><span>Source:Seeking Alpha</span></p>\n<p>I think you’ll struggle to find a company with a better earnings revision schedule, as the past three months have seen 36 EPS revisions, and<i>100%</i>of them were upward. That shows just how strong Apple’s earnings trajectory is, as analysts scramble to meet Apple’s outstanding performances. I love stocks with earnings revision charts like Apple’s because the bar is always rising, which means that the stock will follow suit.</p>\n<p><b>Not all is well</b></p>\n<p>Apple, to be fair, does face a huge amount of risks that are outside of its control. Many of them cropped up since my last report on Apple and so I want to balance my bullish position on the stock with some sobering reality to ensure readers are well-equipped to make an informed decision about whether or not Apple is right for their portfolio.</p>\n<p>First, the FTC made the headlines a few weeks ago by appointing Lina Khan, an outspoken and noted big tech critic, who feels certain companies have too much control over the behaviors of consumers. This is a noteworthy development because if the FTC wants to go after big tech, Apple is a very logical early target. I don’t see it impacting iPhone or other hardware sales but services revenue? Absolutely. This is a longer-term threat since antitrust rules take time to create, but Apple shareholders need to take this threat seriously.</p>\n<p>The White Houseis apparently on board with this line of thinking, and the House is actually considering legislation that would undertake to reign in the perceived control of big tech companies, including Apple's tendency to pre-install its own apps on Apple devices. Would that stop consumers from just going to the app store and downloading them? No, but it certainly isn't a<i>positive</i> catalyst.</p>\n<p>Apple is facing a similar threat in Germany and other places in the developed world, so it isn’t just a problem at home. Germany is assessing if Apple has “competition violations” to be addressed. So the issue is the same one being faced in the US, and the only two outcomes are neutral (nothing happens), or negative (antitrust action is taken).</p>\n<p>Apple is also still very much beholden to the never-ending trade war between China and the US, as the two countries constantly jockey for position with the highest stakes the world has ever seen in such a scuffle. Apple’s production process is potentially at risk, depending upon how ugly things get, adding some geopolitical risk to the stock's outlook. This goes both ways, and China employs a lot of people and generates a lot of cash from Apple’s production. So I’m not sure it is as one-sided as it seems, but the geopolitical risk is never a good thing, and Apple’s manufacturing needs set it up for such a risk.</p>\n<p><b>Final thoughts</b></p>\n<p>I’ve enumerated a variety of potential issues Apple is facing, and I’ll be clear and say none of these are good things. The best possible outcome is that nothing changes, and the worst is that all come to fruition and Apple faces manufacturing challenges, as well as antitrust actions. These are real threats, but I also think they're already priced in.</p>\n<p>The threat of antitrust legislation or a trade war with China isn’t new by any stretch of the imagination and is not dissimilar to the threats that other tech giants like Amazon (AMZN), Alphabet (GOOG), or Facebook (FB) face every day. This is par for the course if you’re a dominant tech company, and Apple certainly is. I don’t want to ignore these potential negative catalysts, but I don’t want to overreact, either.</p>\n<p>Keep in mind also that Apple continues to move higher over time despite this bad news, which is what winning stocks do. The fact that it is shrugging off these huge potential negative catalysts reinforces the bullish stance I already had on the stock.</p>\n<p>I detailed my bullishness on the company’s revenue generation, margins, buybacks, valuation, and more in the prior piece, and nothing has changed there. So I don’t want to waste your time going through it again. However, my fundamental stance on Apple hasn’t changed in the past six weeks, and if anything, continued upward revisions in EPS estimates have strengthened the bull case.</p>\n<p>The important thing is that shareholders must be aware of external threats, but also that we are seeing Apple get to the end of its very bullish consolidation pattern at the same time that it typically begins a pre-earnings run higher.</p>\n<p>The bottom line is that I think Apple’s breakout is imminent, and that the pattern measures to $172 or so. This won’t happen overnight, but if you were looking to buy Apple, act quickly.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple: Act Quickly Before The Run To $172</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple: Act Quickly Before The Run To $172\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-30 14:54 GMT+8 <a href=https://seekingalpha.com/article/4437069-apple-act-quickly-before-the-run-to-172><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Summary\n\nApple faces many external threats from regulators in the developed world.\nBut I see these as largely priced in, although they remain a threat longer term.\nApple is on the cusp of what should ...</p>\n\n<a href=\"https://seekingalpha.com/article/4437069-apple-act-quickly-before-the-run-to-172\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://seekingalpha.com/article/4437069-apple-act-quickly-before-the-run-to-172","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1110936297","content_text":"Summary\n\nApple faces many external threats from regulators in the developed world.\nBut I see these as largely priced in, although they remain a threat longer term.\nApple is on the cusp of what should be a pre-earnings run and an imminent breakout of a bullish consolidation pattern.\n\nfMing Yeung/Getty Images News\nI have made it no secret that I’m a big fan of Apple(AAPL). In fact, I wrote a very bullish piece about six weeks ago, detailing how I thought Apple was in the process of consolidating before a big breakout. In this article, I want to update readers on the progress of that, as well as addressing some concerns that could be potentially bearish. But the spoiler alert is that I’m still very much in the camp of Apple setting up a breakout, and I think the company’s typical pre-earnings move is likely the catalyst to see that happen.\nSource: StockCharts\nTo start, I’ve annotated the same ascending triangle formation I noted six weeks ago, because it is still very much in play. The stock is very near the top of the triangle today, so what happens when/if it gets to $136/$137 will determine if the breakout is imminent or if we need at least one more test of the rising trend line that forms the bottom of the triangle. Whether that occurs or not doesn’t change my outlook; only the timing of it.\nAscending triangles measure upside targets on breakouts equal to the top and bottom of the widest part of the triangle. In this case, the top of the triangle is $137 and the bottom of the triangle, which was set in September of last year, was $102. That means that this triangle pattern has a measured price target – after the breakout – of $35 higher ($137 minus $102), and with the breakout point being $137 or so, that implies we canexpect Apple to hit $172, give or take. Now, that won’t happen immediately, of course, but that’s the kind of opportunity at hand here.\nWhat do you need to look for on a breakout? First, price action needs to decisively clear the breakout level of $137 and close above it. In addition, you want to see rising volume on the breakout – I’ve annotated declining volume in the triangle period, which is normal behavior – and you want to see rising momentum, we’ve got rising momentum today. So I’d expect a breakout to continue that, but these are the things you want to see on a breakout to ensure it has staying power.\nFinally, you’ll notice that I’ve added blue circles on the chart, and those represent the start of the ~4-week period prior to an earnings release. Apple has beenveryreliable in the past couple of years in terms of rallying into an earnings report, and I have no reason to think that will change. The gains are fairly large in most cases, with about half of them being in the double-digits, so this is a real catalyst for higher prices.\nThe important thing to note is that we are about four weeks from the third quarter report, which typically takes place at the end of July. We are also at the top of the ascending triangle, which means that even a small pre-earnings run will likely result in a breakout, and that’s why I think the breakout is very near.\nTo be clear, I’m reiterating my prior thesis that an ascending triangle breakout is coming; I just think we have a very clear catalyst now to make it sooner than later. I see the stock rallying into the earnings report, and if history is a guide, Apple will destroy expectations once again. In short, all is going to plan.\nThe risk is that if Apple does break out of the triangle and earnings aren’t very good, the pattern could fail. That would negate my $172 price target, and we’d have to reassess. For now, the odds of that look low, and I’m still full steam ahead on the breakout coming pre-earnings.\nWhy does Apple rally pre-earnings?\nTo put it succinctly, Apple rallies pre-earnings because no matter how much analysts raise their targets going into the reports, Apple finds a way to beat them.\nSource:Seeking Alpha\nThis is three years’ worth of data showing how Apple beats expectations, and by enormous margins in some cases. Apple is one of the largest and most-followed companies that has ever existed. So if any company should have an analyst community that knows how it will perform each quarter, it would be this one. However, its dominance in hardware and services revenue has proven too much for analysts over time to keep up with.\nKeep in mind a risk here is that if Apple does finally miss expectations, I have to imagine the stock will react extremely poorly. Thus, there is certainly risk in owning Apple through the earnings report, as with any other stock. But the company’s history of smashing expectations – particularly in the past year – means the odds of this are fairly low. Still, something to keep in mind from a risk perspective.\nIn terms of a catalyst for rallying into the July report, Apple continues to see analysts scramble to keep up with its rising fortunes.\nSource:Seeking Alpha\nThe sharp upward revisions that began last summer continue unabated, and Apple’s earnings trajectory remains very much intact. I detailed this in my last piece so I’m simply saying that nothing has changed on this front, and that’s a very good thing.\nSource:Seeking Alpha\nI think you’ll struggle to find a company with a better earnings revision schedule, as the past three months have seen 36 EPS revisions, and100%of them were upward. That shows just how strong Apple’s earnings trajectory is, as analysts scramble to meet Apple’s outstanding performances. I love stocks with earnings revision charts like Apple’s because the bar is always rising, which means that the stock will follow suit.\nNot all is well\nApple, to be fair, does face a huge amount of risks that are outside of its control. Many of them cropped up since my last report on Apple and so I want to balance my bullish position on the stock with some sobering reality to ensure readers are well-equipped to make an informed decision about whether or not Apple is right for their portfolio.\nFirst, the FTC made the headlines a few weeks ago by appointing Lina Khan, an outspoken and noted big tech critic, who feels certain companies have too much control over the behaviors of consumers. This is a noteworthy development because if the FTC wants to go after big tech, Apple is a very logical early target. I don’t see it impacting iPhone or other hardware sales but services revenue? Absolutely. This is a longer-term threat since antitrust rules take time to create, but Apple shareholders need to take this threat seriously.\nThe White Houseis apparently on board with this line of thinking, and the House is actually considering legislation that would undertake to reign in the perceived control of big tech companies, including Apple's tendency to pre-install its own apps on Apple devices. Would that stop consumers from just going to the app store and downloading them? No, but it certainly isn't apositive catalyst.\nApple is facing a similar threat in Germany and other places in the developed world, so it isn’t just a problem at home. Germany is assessing if Apple has “competition violations” to be addressed. So the issue is the same one being faced in the US, and the only two outcomes are neutral (nothing happens), or negative (antitrust action is taken).\nApple is also still very much beholden to the never-ending trade war between China and the US, as the two countries constantly jockey for position with the highest stakes the world has ever seen in such a scuffle. Apple’s production process is potentially at risk, depending upon how ugly things get, adding some geopolitical risk to the stock's outlook. This goes both ways, and China employs a lot of people and generates a lot of cash from Apple’s production. So I’m not sure it is as one-sided as it seems, but the geopolitical risk is never a good thing, and Apple’s manufacturing needs set it up for such a risk.\nFinal thoughts\nI’ve enumerated a variety of potential issues Apple is facing, and I’ll be clear and say none of these are good things. The best possible outcome is that nothing changes, and the worst is that all come to fruition and Apple faces manufacturing challenges, as well as antitrust actions. These are real threats, but I also think they're already priced in.\nThe threat of antitrust legislation or a trade war with China isn’t new by any stretch of the imagination and is not dissimilar to the threats that other tech giants like Amazon (AMZN), Alphabet (GOOG), or Facebook (FB) face every day. This is par for the course if you’re a dominant tech company, and Apple certainly is. I don’t want to ignore these potential negative catalysts, but I don’t want to overreact, either.\nKeep in mind also that Apple continues to move higher over time despite this bad news, which is what winning stocks do. The fact that it is shrugging off these huge potential negative catalysts reinforces the bullish stance I already had on the stock.\nI detailed my bullishness on the company’s revenue generation, margins, buybacks, valuation, and more in the prior piece, and nothing has changed there. So I don’t want to waste your time going through it again. However, my fundamental stance on Apple hasn’t changed in the past six weeks, and if anything, continued upward revisions in EPS estimates have strengthened the bull case.\nThe important thing is that shareholders must be aware of external threats, but also that we are seeing Apple get to the end of its very bullish consolidation pattern at the same time that it typically begins a pre-earnings run higher.\nThe bottom line is that I think Apple’s breakout is imminent, and that the pattern measures to $172 or so. This won’t happen overnight, but if you were looking to buy Apple, act quickly.","news_type":1},"isVote":1,"tweetType":1,"viewCount":199,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":124445119,"gmtCreate":1624785591931,"gmtModify":1633948630367,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087463284623270","idStr":"4087463284623270"},"themes":[],"htmlText":"Okay","listText":"Okay","text":"Okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/124445119","repostId":"2146006003","repostType":4,"isVote":1,"tweetType":1,"viewCount":156,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":606310868,"gmtCreate":1638833792463,"gmtModify":1638833792463,"author":{"id":"4087463284623270","authorId":"4087463284623270","name":"PCQ","avatar":"https://static.tigerbbs.com/04e7fec5ae39ae018a16e0673ae18893","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087463284623270","idStr":"4087463284623270"},"themes":[],"htmlText":"okay","listText":"okay","text":"okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/606310868","repostId":"1191828969","repostType":2,"repost":{"id":"1191828969","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638792831,"share":"https://www.laohu8.com/m/news/1191828969?lang=&edition=full","pubTime":"2021-12-06 20:13","market":"us","language":"en","title":"Grab shares slid more than 4% in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1191828969","media":"Tiger Newspress","summary":"Grab shares slid more than 4% in premarket trading.The Singapore ride-hailing firm went on sale last week.","content":"<p>Grab shares slid more than 4% in premarket trading.The Singapore ride-hailing firm went on sale last week.</p>\n<p><img src=\"https://static.tigerbbs.com/8de30b544b65a645e7a91a37bfb8d8f8\" tg-width=\"851\" tg-height=\"618\" width=\"100%\" height=\"auto\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Grab shares slid more than 4% in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGrab shares slid more than 4% in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-06 20:13</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Grab shares slid more than 4% in premarket trading.The Singapore ride-hailing firm went on sale last week.</p>\n<p><img src=\"https://static.tigerbbs.com/8de30b544b65a645e7a91a37bfb8d8f8\" tg-width=\"851\" tg-height=\"618\" width=\"100%\" height=\"auto\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GRAB":"Grab Holdings"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1191828969","content_text":"Grab shares slid more than 4% in premarket trading.The Singapore ride-hailing firm went on sale last week.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1140,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}